{
    "abstract": "Seasonal influenza virus infections cause significant morbidity and mortality every year. Annual influenza virus vaccines are effective but only when well matched with circulating strains. Therefore, there is an urgent need for better vaccines that induce broad protection against drifted seasonal and emerging pandemic influenza viruses. One approach to design such vaccines is based on targeting conserved regions of the influenza virus hemagglutinin. Sequential vaccination with chimeric hemagglutinin constructs can refocus antibody responses towards the conserved immunosubdominant stalk domain of the hemagglutinin, rather than the variable immunodominant head. A complementary approach for a universal influenza A virus vaccine is to induce T-cell responses to conserved internal influenza virus antigens. For this purpose, replication deficient recombinant viral vectors based on Chimpanzee Adenovirus Oxford 1 and Modified Vaccinia Ankara virus are used to express the viral nucleoprotein and the matrix protein 1. In this study, we combined these two strategies and evaluated the efficacy of viral vectors expressing both chimeric hemagglutinin and nucleoprotein plus matrix protein 1 in a mouse model against challenge with group 2 influenza viruses including H3N2, H7N9 and H10N8. We found that vectored vaccines expressing both sets of antigens provided enhanced protection against H3N2 virus challenge when compared to vaccination with viral vectors expressing only one set of antigens. Vaccine induced antibody responses against divergent group 2 hemagglutinins, nucleoprotein and matrix protein 1 as well as robust T-cell responses to the nucleoprotein and matrix protein 1 were detected. Of note, it was observed that while antibodies to the H3 stalk were already boosted to high levels after two vaccinations with chimeric hemagglutinins (cHAs), three exposures were required to induce strong reactivity across subtypes. Overall, these results show that a combinations of different universal influenza virus vaccine strategies can induce broad antibody and T-cell responses and can provide increased protection against influenza.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1038/s41577-019-0143-6",
            "firstpage": "383",
            "issn": "14741733",
            "lastpage": "397",
            "pmid": "30837674",
            "pub_year": 2019,
            "title": "The human antibody response to influenza A virus infection and vaccination",
            "volume": "19"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Hang",
                    "initial": "H.",
                    "last": "Xie"
                },
                {
                    "first": "Xiu Feng",
                    "initial": "X.F.",
                    "last": "Wan"
                },
                {
                    "first": "Zhiping",
                    "initial": "Z.",
                    "last": "Ye"
                },
                {
                    "first": "Ewan P.",
                    "initial": "E.P.",
                    "last": "Plant"
                },
                {
                    "first": "Yangqing",
                    "initial": "Y.",
                    "last": "Zhao"
                },
                {
                    "first": "Yifei",
                    "initial": "Y.",
                    "last": "Xu"
                },
                {
                    "first": "Xing",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Courtney",
                    "initial": "C.",
                    "last": "Finch"
                },
                {
                    "first": "Nan",
                    "initial": "N.",
                    "last": "Zhao"
                },
                {
                    "first": "Toshiaki",
                    "initial": "T.",
                    "last": "Kawano"
                },
                {
                    "first": "Olga",
                    "initial": "O.",
                    "last": "Zoueva"
                },
                {
                    "first": "Meng Jung",
                    "initial": "M.J.",
                    "last": "Chiang"
                },
                {
                    "first": "Xianghong",
                    "initial": "X.",
                    "last": "Jing"
                },
                {
                    "first": "Zhengshi",
                    "initial": "Z.",
                    "last": "Lin"
                },
                {
                    "first": "Anding",
                    "initial": "A.",
                    "last": "Zhang"
                },
                {
                    "first": "Yanhong",
                    "initial": "Y.",
                    "last": "Zhu"
                }
            ],
            "doi": "10.1038/srep15279",
            "issn": "20452322",
            "pmid": "26472175",
            "pub_year": 2015,
            "title": "H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps",
            "volume": "5"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Jan C.",
                    "initial": "J.C.",
                    "last": "De Jong"
                },
                {
                    "first": "Walter E.P.",
                    "initial": "W.E.P.",
                    "last": "Beyer"
                },
                {
                    "first": "Abraham M.",
                    "initial": "A.M.",
                    "last": "Palache"
                },
                {
                    "first": "Guus F.",
                    "initial": "G.F.",
                    "last": "Rimmelzwaan"
                },
                {
                    "first": "Albert D.M.E.",
                    "initial": "A.D.M.E.",
                    "last": "Osterhaus"
                }
            ],
            "doi": "10.1002/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C",
            "firstpage": "94",
            "issn": "01466615",
            "lastpage": "99",
            "pmid": "10745239",
            "pub_year": 2000,
            "title": "Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly",
            "volume": "61"
        },
        "b0020": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1016/j.cmi.2017.02.009",
            "firstpage": "222",
            "issn": "1198743X",
            "lastpage": "228",
            "pmid": "28216325",
            "pub_year": 2017,
            "title": "Universal influenza virus vaccines and therapeutic antibodies",
            "volume": "23"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Sebastian"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                }
            ],
            "doi": "10.3390/vaccines6020029",
            "issn": "2076393X",
            "pub_year": 2018,
            "title": "Clinical advances in viral-vectored influenza vaccines",
            "volume": "6"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Raffael",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                }
            ],
            "doi": "10.1016/j.coi.2018.04.001",
            "firstpage": "51",
            "issn": "09527915",
            "lastpage": "57",
            "pmid": "29680576",
            "pub_year": 2018,
            "title": "Development of next generation hemagglutinin-based broadly protective influenza virus vaccines",
            "volume": "53"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Isakova-Sivak"
                },
                {
                    "first": "Daniil",
                    "initial": "D.",
                    "last": "Korenkov"
                },
                {
                    "first": "Tatiana",
                    "initial": "T.",
                    "last": "Smolonogina"
                },
                {
                    "first": "Tatiana",
                    "initial": "T.",
                    "last": "Kotomina"
                },
                {
                    "first": "Svetlana",
                    "initial": "S.",
                    "last": "Donina"
                },
                {
                    "first": "Victoria",
                    "initial": "V.",
                    "last": "Matyushenko"
                },
                {
                    "first": "Daria",
                    "initial": "D.",
                    "last": "Mezhenskaya"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Larisa",
                    "initial": "L.",
                    "last": "Rudenko"
                }
            ],
            "doi": "10.1016/j.virol.2018.03.013",
            "firstpage": "313",
            "issn": "00426822",
            "lastpage": "323",
            "pmid": "29574336",
            "pub_year": 2018,
            "title": "Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin",
            "volume": "518"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Raffael",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Kinzler"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Choi"
                },
                {
                    "first": "Ariana",
                    "initial": "A.",
                    "last": "Hirsh"
                },
                {
                    "first": "Edith",
                    "initial": "E.",
                    "last": "Beaulieu"
                },
                {
                    "first": "Nicolas",
                    "initial": "N.",
                    "last": "Lecrenier"
                },
                {
                    "first": "Bruce L.",
                    "initial": "B.L.",
                    "last": "Innis"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "Corey P.",
                    "initial": "C.P.",
                    "last": "Mallett"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1038/npjvaccines.2016.15",
            "issn": "20590105",
            "pub_year": 2016,
            "title": "A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice",
            "volume": "1"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Megan E.",
                    "initial": "M.E.",
                    "last": "Ermler"
                },
                {
                    "first": "Ericka",
                    "initial": "E.",
                    "last": "Kirkpatrick"
                },
                {
                    "first": "Weina",
                    "initial": "W.",
                    "last": "Sun"
                },
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "Fatima",
                    "initial": "F.",
                    "last": "Amanat"
                },
                {
                    "first": "Veronika",
                    "initial": "V.",
                    "last": "Chromikova"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1128/JVI.00286-17",
            "issn": "0022538X",
            "pmid": "28356526",
            "pub_year": 2017,
            "title": "Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model",
            "volume": "91"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Natalie",
                    "initial": "N.",
                    "last": "Pica"
                },
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palesea"
                }
            ],
            "doi": "10.1128/JVI.00641-13",
            "firstpage": "6542",
            "issn": "0022538X",
            "lastpage": "6550",
            "pmid": "23576508",
            "pub_year": 2013,
            "title": "Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies",
            "volume": "87"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "Alexander",
                    "initial": "A.",
                    "last": "Flood"
                },
                {
                    "first": "Ariana",
                    "initial": "A.",
                    "last": "Hirsh"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Tsvetnitsky"
                },
                {
                    "first": "Dexiang",
                    "initial": "D.",
                    "last": "Chen"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                }
            ],
            "doi": "10.1128/JVI.03183-13",
            "firstpage": "2340",
            "issn": "0022538X",
            "lastpage": "2343",
            "pmid": "24307585",
            "pub_year": 2014,
            "title": "H3 Stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge",
            "volume": "88"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Raffael",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Randy A.",
                    "initial": "R.A.",
                    "last": "Albrecht"
                }
            ],
            "doi": "10.3390/vaccines6030047",
            "issn": "2076393X",
            "pub_year": 2018,
            "title": "A live-attenuated prime, inactivated boost vaccination strategy with chimeric hemagglutinin-based universal influenza virus vaccines provides protection in ferrets: A confirmatory study",
            "volume": "6"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Raffael",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "Wen Chun",
                    "initial": "W.C.",
                    "last": "Liu"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Choi"
                },
                {
                    "first": "Teddy John",
                    "initial": "T.J.",
                    "last": "Wohlbold"
                },
                {
                    "first": "Talia",
                    "initial": "T.",
                    "last": "Atlas"
                },
                {
                    "first": "Madhusudan",
                    "initial": "M.",
                    "last": "Rajendran"
                },
                {
                    "first": "Alicia",
                    "initial": "A.",
                    "last": "Sol\u00f3rzano"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berlanda-Scorza"
                },
                {
                    "first": "Adolfo",
                    "initial": "A.",
                    "last": "Garci\u00e1-Sastre"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "Randy A.",
                    "initial": "R.A.",
                    "last": "Albrecht"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1038/s41541-017-0026-4",
            "issn": "20590105",
            "pub_year": 2017,
            "title": "A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies",
            "volume": "2"
        },
        "b0070": {
            "authors": [
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "N. S.",
                    "initial": "N.S.",
                    "last": "Heaton"
                },
                {
                    "first": "G. S.",
                    "initial": "G.S.",
                    "last": "Tan"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "Andrews"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Runstadler"
                },
                {
                    "first": "P. C.",
                    "initial": "P.C.",
                    "last": "Wilson"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Albrecht"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Garc\u00eda-Sastre"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Palesea"
                }
            ],
            "doi": "10.1128/JVI.01715-13",
            "firstpage": "10435",
            "issn": "0022538X",
            "lastpage": "10446",
            "pmid": "23903831",
            "pub_year": 2013,
            "title": "Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses",
            "volume": "87"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Yondola"
                },
                {
                    "first": "Gene S.",
                    "initial": "G.S.",
                    "last": "Tan"
                },
                {
                    "first": "Victor H.",
                    "initial": "V.H.",
                    "last": "Leyva-Grado"
                },
                {
                    "first": "Alex B.",
                    "initial": "A.B.",
                    "last": "Ryder"
                },
                {
                    "first": "Matthew S.",
                    "initial": "M.S.",
                    "last": "Miller"
                },
                {
                    "first": "John K.",
                    "initial": "J.K.",
                    "last": "Rose"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "Adolfo",
                    "initial": "A.",
                    "last": "Garc\u00eda-Sastre"
                },
                {
                    "first": "Randy A.",
                    "initial": "R.A.",
                    "last": "Albrecht"
                }
            ],
            "doi": "10.1128/JVI.03004-13",
            "firstpage": "3432",
            "issn": "0022538X",
            "lastpage": "3442",
            "pmid": "24403585",
            "pub_year": 2014,
            "title": "Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets",
            "volume": "88"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Raffael",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "Matthew S.",
                    "initial": "M.S.",
                    "last": "Miller"
                },
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "Alex B.",
                    "initial": "A.B.",
                    "last": "Ryder"
                },
                {
                    "first": "John K.",
                    "initial": "J.K.",
                    "last": "Rose"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "Adolfo",
                    "initial": "A.",
                    "last": "Garc\u00eda-Sastre"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Randy A.",
                    "initial": "R.A.",
                    "last": "Albrecht"
                }
            ],
            "doi": "10.1128/JVI.02481-15",
            "firstpage": "3268",
            "issn": "0022538X",
            "lastpage": "3273",
            "pmid": "26719251",
            "pub_year": 2016,
            "title": "Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets",
            "volume": "90"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Alex B.",
                    "initial": "A.B.",
                    "last": "Ryder"
                },
                {
                    "first": "Raffael",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Buonocore"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "John K.",
                    "initial": "J.K.",
                    "last": "Rose"
                }
            ],
            "doi": "10.1128/JVI.02598-15",
            "firstpage": "2544",
            "issn": "0022538X",
            "lastpage": "2550",
            "pmid": "26676789",
            "pub_year": 2016,
            "title": "Vaccination with vesicular stomatitis virus-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains",
            "volume": "90"
        },
        "b0090": {
            "authors": [
                {
                    "first": "J. L.",
                    "initial": "J.L.",
                    "last": "SCHULMAN"
                },
                {
                    "first": "E. D.",
                    "initial": "E.D.",
                    "last": "KILBOURNE"
                }
            ],
            "firstpage": "170",
            "issn": "00219193",
            "lastpage": "174",
            "pmid": "14255658",
            "pub_year": 1965,
            "title": "INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE",
            "volume": "89"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Jeffrey B.",
                    "initial": "J.B.",
                    "last": "Ulmer"
                },
                {
                    "first": "Tong Ming",
                    "initial": "T.M.",
                    "last": "Fu"
                },
                {
                    "first": "R. Randall",
                    "initial": "R.R.",
                    "last": "Deck"
                },
                {
                    "first": "Arthur",
                    "initial": "A.",
                    "last": "Friedman"
                },
                {
                    "first": "Liming",
                    "initial": "L.",
                    "last": "Guan"
                },
                {
                    "first": "Corrille",
                    "initial": "C.",
                    "last": "DeWitt"
                },
                {
                    "first": "Xu",
                    "initial": "X.",
                    "last": "Liu"
                },
                {
                    "first": "Su",
                    "initial": "S.",
                    "last": "Wang"
                },
                {
                    "first": "Margaret A.",
                    "initial": "M.A.",
                    "last": "Liu"
                },
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Donnelly"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Caulfield"
                }
            ],
            "firstpage": "5648",
            "issn": "0022538X",
            "lastpage": "5653",
            "pmid": "9621023",
            "pub_year": 1998,
            "title": "Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA",
            "volume": "72"
        },
        "b0100": {
            "authors": [
                {
                    "first": "J. H.C.M.",
                    "initial": "J.H.C.M.",
                    "last": "Kreijtz"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Bodewes"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "van Amerongen"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Kuiken"
                },
                {
                    "first": "R. A.M.",
                    "initial": "R.A.M.",
                    "last": "Fouchier"
                },
                {
                    "first": "A. D.M.E.",
                    "initial": "A.D.M.E.",
                    "last": "Osterhaus"
                },
                {
                    "first": "G. F.",
                    "initial": "G.F.",
                    "last": "Rimmelzwaan"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.08.036",
            "firstpage": "612",
            "issn": "0264410X",
            "lastpage": "620",
            "pmid": "17005299",
            "pub_year": 2007,
            "title": "Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice",
            "volume": "25"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Mcmichael"
                },
                {
                    "first": "Frances M.",
                    "initial": "F.M.",
                    "last": "Gotch"
                },
                {
                    "first": "Gary R.",
                    "initial": "G.R.",
                    "last": "Noble"
                },
                {
                    "first": "Paul A.S.",
                    "initial": "P.A.S.",
                    "last": "Beare"
                }
            ],
            "doi": "10.1056/NEJM198307073090103",
            "firstpage": "13",
            "issn": "00284793",
            "lastpage": "17",
            "pmid": "6602294",
            "pub_year": 1983,
            "title": "Cytotoxic T-Cell Immunity to Influenza",
            "volume": "309"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Andrew C.",
                    "initial": "A.C.",
                    "last": "Hayward"
                },
                {
                    "first": "Lili",
                    "initial": "L.",
                    "last": "Wang"
                },
                {
                    "first": "Nilu",
                    "initial": "N.",
                    "last": "Goonetilleke"
                },
                {
                    "first": "Ellen B.",
                    "initial": "E.B.",
                    "last": "Fragaszy"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Bermingham"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Copas"
                },
                {
                    "first": "Oliver",
                    "initial": "O.",
                    "last": "Dukes"
                },
                {
                    "first": "Elizabeth R.C.",
                    "initial": "E.R.C.",
                    "last": "Millett"
                },
                {
                    "first": "Irwin",
                    "initial": "I.",
                    "last": "Nazareth"
                },
                {
                    "first": "Jonathan S.",
                    "initial": "J.S.",
                    "last": "Nguyen-Van-Tam"
                },
                {
                    "first": "John M.",
                    "initial": "J.M.",
                    "last": "Watson"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Zambon"
                },
                {
                    "first": "Anne M.",
                    "initial": "A.M.",
                    "last": "Johnson"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "McMichael"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1164/rccm.201411-1988OC",
            "firstpage": "1422",
            "issn": "1073449X",
            "lastpage": "1431",
            "pmid": "25844934",
            "pub_year": 2015,
            "title": "Natural T cell-mediated protection against seasonal and pandemic influenza: Results of the flu watch cohort study",
            "volume": "191"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Tom M.",
                    "initial": "T.M.",
                    "last": "Wilkinson"
                },
                {
                    "first": "Chris K.F.",
                    "initial": "C.K.F.",
                    "last": "Li"
                },
                {
                    "first": "Cecilia S.C.",
                    "initial": "C.S.C.",
                    "last": "Chui"
                },
                {
                    "first": "Arthur K.Y.",
                    "initial": "A.K.Y.",
                    "last": "Huang"
                },
                {
                    "first": "Molly",
                    "initial": "M.",
                    "last": "Perkins"
                },
                {
                    "first": "Julia C.",
                    "initial": "J.C.",
                    "last": "Liebner"
                },
                {
                    "first": "Rob",
                    "initial": "R.",
                    "last": "Lambkin-Williams"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Gilbert"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Oxford"
                },
                {
                    "first": "Ben",
                    "initial": "B.",
                    "last": "Nicholas"
                },
                {
                    "first": "Karl J.",
                    "initial": "K.J.",
                    "last": "Staples"
                },
                {
                    "first": "Tao",
                    "initial": "T.",
                    "last": "Dong"
                },
                {
                    "first": "Daniel C.",
                    "initial": "D.C.",
                    "last": "Douek"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "McMichael"
                },
                {
                    "first": "Xiao Ning",
                    "initial": "X.N.",
                    "last": "Xu"
                }
            ],
            "doi": "10.1038/nm.2612",
            "firstpage": "274",
            "issn": "10788956",
            "lastpage": "280",
            "pmid": "22286307",
            "pub_year": 2012,
            "title": "Preexisting influenza-specific CD4 + T cells correlate with disease protection against influenza challenge in humans",
            "volume": "18"
        },
        "b0120": {
            "authors": [
                {
                    "first": "E. Bridie",
                    "initial": "E.B.",
                    "last": "Clemens"
                },
                {
                    "first": "Carolien",
                    "initial": "C.",
                    "last": "Van de Sandt"
                },
                {
                    "first": "Sook San",
                    "initial": "S.S.",
                    "last": "Wong"
                },
                {
                    "first": "Linda M.",
                    "initial": "L.M.",
                    "last": "Wakim"
                },
                {
                    "first": "Sophie A.",
                    "initial": "S.A.",
                    "last": "Valkenburg"
                }
            ],
            "doi": "10.3390/vaccines6020018",
            "issn": "2076393X",
            "pub_year": 2018,
            "title": "Harnessing the power of T cells: The promising hope for a universal influenza vaccine",
            "volume": "6"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Janet E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "George A.",
                    "initial": "G.A.",
                    "last": "Kuchel"
                },
                {
                    "first": "Xin",
                    "initial": "X.",
                    "last": "Zhou"
                },
                {
                    "first": "Susan L.",
                    "initial": "S.L.",
                    "last": "Swain"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Haynes"
                }
            ],
            "doi": "10.3389/fimmu.2016.00041",
            "issn": "16643224",
            "pub_year": 2016,
            "title": "T-cell immunity to influenza in older adults: A pathophysiological framework for development of more effective vaccines",
            "volume": "7"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Antrobus"
                },
                {
                    "first": "Lynda",
                    "initial": "L.",
                    "last": "Coughlan"
                },
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Dicks"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1038/mt.2013.284",
            "firstpage": "668",
            "issn": "15250016",
            "lastpage": "674",
            "pmid": "24374965",
            "pub_year": 2014,
            "title": "Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens",
            "volume": "22"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Antrobus"
                },
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Caitlin E.",
                    "initial": "C.E.",
                    "last": "Mullarkey"
                },
                {
                    "first": "Katja",
                    "initial": "K.",
                    "last": "Hoschler"
                },
                {
                    "first": "Lynda",
                    "initial": "L.",
                    "last": "Coughlan"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Zambon"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1038/mt.2013.162",
            "firstpage": "233",
            "issn": "15250016",
            "lastpage": "238",
            "pmid": "23831594",
            "pub_year": 2014,
            "title": "Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses",
            "volume": "22"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Timothy J.",
                    "initial": "T.J.",
                    "last": "Powell"
                },
                {
                    "first": "Yanchun",
                    "initial": "Y.",
                    "last": "Peng"
                },
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Marie Eve",
                    "initial": "M.E.",
                    "last": "Blais"
                },
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Lillie"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Sarah L.",
                    "initial": "S.L.",
                    "last": "Rowland-Jones"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "McMichael"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Tao",
                    "initial": "T.",
                    "last": "Dong"
                }
            ],
            "doi": "10.1371/journal.pone.0062778",
            "issn": "19326203",
            "pmid": "23658773",
            "pub_year": 2013,
            "title": "Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine",
            "volume": "8"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Carey"
                },
                {
                    "first": "Yuanyuan",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Arjan",
                    "initial": "A.",
                    "last": "Van Laarhoven"
                },
                {
                    "first": "Caitlin E.",
                    "initial": "C.E.",
                    "last": "Mullarkey"
                },
                {
                    "first": "Anto",
                    "initial": "A.",
                    "last": "Vrdoljak"
                },
                {
                    "first": "Anne C.",
                    "initial": "A.C.",
                    "last": "Moore"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1038/srep01443",
            "issn": "20452322",
            "pmid": "23485942",
            "pub_year": 2013,
            "title": "Immunity against heterosubtypic influenza virus induced by adenovirus and mva expressing nucleoprotein and matrix protein-1",
            "volume": "3"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Hamill"
                },
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Lillie"
                },
                {
                    "first": "Lenias",
                    "initial": "L.",
                    "last": "Hwenda"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Milicic"
                },
                {
                    "first": "Hazel C.",
                    "initial": "H.C.",
                    "last": "Poyntz"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Helen A.",
                    "initial": "H.A.",
                    "last": "Fletcher"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1093/cid/ciq015",
            "firstpage": "1",
            "issn": "10584838",
            "lastpage": "7",
            "pmid": "21148512",
            "pub_year": 2011,
            "title": "Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza a vaccine, MVA-NP+M1",
            "volume": "52"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Lillie"
                },
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Timothy J.",
                    "initial": "T.J.",
                    "last": "Powell"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Caitlin",
                    "initial": "C.",
                    "last": "Mullarkey"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Hamill"
                },
                {
                    "first": "Yanchun",
                    "initial": "Y.",
                    "last": "Peng"
                },
                {
                    "first": "Marie Eve",
                    "initial": "M.E.",
                    "last": "Blais"
                },
                {
                    "first": "Christopher J.A.",
                    "initial": "C.J.A.",
                    "last": "Duncan"
                },
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Sheehy"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Havelock"
                },
                {
                    "first": "Saul N.",
                    "initial": "S.N.",
                    "last": "Faust"
                },
                {
                    "first": "Rob Lambkin",
                    "initial": "R.L.",
                    "last": "Williams"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Gilbert"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Oxford"
                },
                {
                    "first": "Tao",
                    "initial": "T.",
                    "last": "Dong"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1093/cid/cis327",
            "firstpage": "19",
            "issn": "10584838",
            "lastpage": "25",
            "pmid": "22441650",
            "pub_year": 2012,
            "title": "Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans",
            "volume": "55"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Antrobus"
                },
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Lillie"
                },
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "James E.",
                    "initial": "J.E.",
                    "last": "McLaren"
                },
                {
                    "first": "Kristin",
                    "initial": "K.",
                    "last": "Ladell"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Milicic"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Price"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1371/journal.pone.0048322",
            "issn": "19326203",
            "pmid": "23118984",
            "pub_year": 2012,
            "title": "A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years",
            "volume": "7"
        },
        "b0165": {
            "authors": [
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Coughlan"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Sridhar"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Payne"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Edmans"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Milicic"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Venkatraman"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Lugonja"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Clifton"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Qi"
                },
                {
                    "first": "P. M.",
                    "initial": "P.M.",
                    "last": "Folegatti"
                },
                {
                    "first": "A. M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Roberts"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "de Graaf"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Sukhtankar"
                },
                {
                    "first": "S. N.",
                    "initial": "S.N.",
                    "last": "Faust"
                },
                {
                    "first": "D. J.M.",
                    "initial": "D.J.M.",
                    "last": "Lewis"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "A. V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1016/j.ebiom.2018.02.011",
            "firstpage": "146",
            "issn": "23523964",
            "lastpage": "154",
            "pmid": "29519670",
            "pub_year": 2018,
            "title": "Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults",
            "volume": "29"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Claire M.",
                    "initial": "C.M.",
                    "last": "Tully"
                },
                {
                    "first": "Senthil",
                    "initial": "S.",
                    "last": "Chinnakannan"
                },
                {
                    "first": "Caitlin E.",
                    "initial": "C.E.",
                    "last": "Mullarkey"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Ulaszewska"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Ferrara"
                },
                {
                    "first": "Nigel",
                    "initial": "N.",
                    "last": "Temperton"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                }
            ],
            "doi": "10.4049/jimmunol.1600939",
            "firstpage": "1333",
            "issn": "00221767",
            "lastpage": "1341",
            "pub_year": 2017,
            "title": "Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge",
            "volume": "199"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Caitlin E.",
                    "initial": "C.E.",
                    "last": "Mullarkey"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Boyd"
                },
                {
                    "first": "Arjan",
                    "initial": "A.",
                    "last": "Van Laarhoven"
                },
                {
                    "first": "Eric A.",
                    "initial": "E.A.",
                    "last": "Lefevre"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Veronica Carr"
                },
                {
                    "first": "Massimiliano",
                    "initial": "M.",
                    "last": "Baratelli"
                },
                {
                    "first": "Eleonora",
                    "initial": "E.",
                    "last": "Molesti"
                },
                {
                    "first": "Nigel J.",
                    "initial": "N.J.",
                    "last": "Temperton"
                },
                {
                    "first": "Colin",
                    "initial": "C.",
                    "last": "Butter"
                },
                {
                    "first": "Bryan",
                    "initial": "B.",
                    "last": "Charleston"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1002/eji.201242922",
            "firstpage": "1940",
            "issn": "00142980",
            "lastpage": "1952",
            "pmid": "23589155",
            "pub_year": 2013,
            "title": "Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine",
            "volume": "43"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "firstpage": "e51112",
            "issn": "1940087X",
            "pmid": "24300384",
            "pub_year": 2013,
            "title": "Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system."
        },
        "b0185": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Gene S.",
                    "initial": "G.S.",
                    "last": "Tan"
                },
                {
                    "first": "Natalie",
                    "initial": "N.",
                    "last": "Pica"
                },
                {
                    "first": "Jens C.",
                    "initial": "J.C.",
                    "last": "Krause"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                }
            ],
            "doi": "10.1371/journal.pone.0043603",
            "issn": "19326203",
            "pmid": "22928001",
            "pub_year": 2012,
            "title": "A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant Hemagglutinin substrates",
            "volume": "7"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Pavot"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Sebastian"
                },
                {
                    "first": "Alison V.",
                    "initial": "A.V.",
                    "last": "Turner"
                },
                {
                    "first": "Jake",
                    "initial": "J.",
                    "last": "Matthews"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1007/978-1-4939-6869-5_6",
            "firstpage": "97",
            "issn": "10643745",
            "lastpage": "119",
            "pmid": "28374245",
            "pub_year": 2017,
            "title": "Generation and production of modified vaccinia virus Ankara (MVA) as a vaccine vector",
            "volume": "1581"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Toritse",
                    "initial": "T.",
                    "last": "Orubu"
                },
                {
                    "first": "Naif Khalaf",
                    "initial": "N.K.",
                    "last": "Alharbi"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                }
            ],
            "doi": "10.1371/journal.pone.0040167",
            "issn": "19326203",
            "pmid": "22761956",
            "pub_year": 2012,
            "title": "Expression and cellular immunogenicity of a Transgenic Antigen driven by endogenous poxviral early promoters at their authentic loci in MVA",
            "volume": "7"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Zhongde",
                    "initial": "Z.",
                    "last": "Wang"
                },
                {
                    "first": "Joy",
                    "initial": "J.",
                    "last": "Martinez"
                },
                {
                    "first": "Wendi",
                    "initial": "W.",
                    "last": "Zhou"
                },
                {
                    "first": "Corinna",
                    "initial": "C.",
                    "last": "La Rosa"
                },
                {
                    "first": "Tumul",
                    "initial": "T.",
                    "last": "Srivastava"
                },
                {
                    "first": "Anindya",
                    "initial": "A.",
                    "last": "Dasgupta"
                },
                {
                    "first": "Ravindra",
                    "initial": "R.",
                    "last": "Rawal"
                },
                {
                    "first": "Zhongqui",
                    "initial": "Z.",
                    "last": "Li"
                },
                {
                    "first": "William J.",
                    "initial": "W.J.",
                    "last": "Britt"
                },
                {
                    "first": "Don",
                    "initial": "D.",
                    "last": "Diamond"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.11.056",
            "firstpage": "1547",
            "issn": "0264410X",
            "lastpage": "1557",
            "pmid": "19969118",
            "pub_year": 2010,
            "title": "Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines",
            "volume": "28"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Himly"
                },
                {
                    "first": "Douglas N.",
                    "initial": "D.N.",
                    "last": "Foster"
                },
                {
                    "first": "Ivan",
                    "initial": "I.",
                    "last": "Bottoli"
                },
                {
                    "first": "Jason S.",
                    "initial": "J.S.",
                    "last": "Iacovoni"
                },
                {
                    "first": "Peter K.",
                    "initial": "P.K.",
                    "last": "Vogt"
                }
            ],
            "doi": "10.1006/viro.1998.9290",
            "firstpage": "295",
            "issn": "00426822",
            "lastpage": "304",
            "pmid": "9721238",
            "pub_year": 1998,
            "title": "The DF-1 chicken fibroblast cell line: Transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses",
            "volume": "248"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Emily K.",
                    "initial": "E.K.",
                    "last": "Forbes"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.4049/jimmunol.1003783",
            "firstpage": "3738",
            "issn": "00221767",
            "lastpage": "3750",
            "pmid": "21876036",
            "pub_year": 2011,
            "title": "Combining liver- and blood-stage malaria viral-vectored vaccines: Investigating mechanisms of CD8 + T cell interference",
            "volume": "187"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Hadi M.",
                    "initial": "H.M.",
                    "last": "Yassine"
                },
                {
                    "first": "Jeffrey C.",
                    "initial": "J.C.",
                    "last": "Boyington"
                },
                {
                    "first": "Patrick M.",
                    "initial": "P.M.",
                    "last": "McTamney"
                },
                {
                    "first": "Chih Jen",
                    "initial": "C.J.",
                    "last": "Wei"
                },
                {
                    "first": "Masaru",
                    "initial": "M.",
                    "last": "Kanekiyo"
                },
                {
                    "first": "Wing Pui",
                    "initial": "W.P.",
                    "last": "Kong"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Gallagher"
                },
                {
                    "first": "Lingshu",
                    "initial": "L.",
                    "last": "Wang"
                },
                {
                    "first": "Yi",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "M. Gordon",
                    "initial": "M.G.",
                    "last": "Joyce"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Lingwood"
                },
                {
                    "first": "Syed M.",
                    "initial": "S.M.",
                    "last": "Moin"
                },
                {
                    "first": "Hanne",
                    "initial": "H.",
                    "last": "Andersen"
                },
                {
                    "first": "Yoshinobu",
                    "initial": "Y.",
                    "last": "Okuno"
                },
                {
                    "first": "Srinivas S.",
                    "initial": "S.S.",
                    "last": "Rao"
                },
                {
                    "first": "Audray K.",
                    "initial": "A.K.",
                    "last": "Harris"
                },
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Kwong"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                }
            ],
            "doi": "10.1038/nm.3927",
            "firstpage": "1065",
            "issn": "10788956",
            "lastpage": "1070",
            "pmid": "26301691",
            "pub_year": 2015,
            "title": "Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection",
            "volume": "21"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Antonietta",
                    "initial": "A.",
                    "last": "Impagliazzo"
                },
                {
                    "first": "Fin",
                    "initial": "F.",
                    "last": "Milder"
                },
                {
                    "first": "Harmjan",
                    "initial": "H.",
                    "last": "Kuipers"
                },
                {
                    "first": "Michelle V.",
                    "initial": "M.V.",
                    "last": "Wagner"
                },
                {
                    "first": "Xueyong",
                    "initial": "X.",
                    "last": "Zhu"
                },
                {
                    "first": "Ryan M.B.",
                    "initial": "R.M.B.",
                    "last": "Hoffman"
                },
                {
                    "first": "Ruud",
                    "initial": "R.",
                    "last": "Van Meersbergen"
                },
                {
                    "first": "Jeroen",
                    "initial": "J.",
                    "last": "Huizingh"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Wanningen"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Verspuij"
                },
                {
                    "first": "Martijn",
                    "initial": "M.",
                    "last": "De Man"
                },
                {
                    "first": "Zhaoqing",
                    "initial": "Z.",
                    "last": "Ding"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Apetri"
                },
                {
                    "first": "Basak",
                    "initial": "B.",
                    "last": "K\u00fckrer"
                },
                {
                    "first": "Eveline",
                    "initial": "E.",
                    "last": "Sneekes-Vriese"
                },
                {
                    "first": "Danuta",
                    "initial": "D.",
                    "last": "Tomkiewicz"
                },
                {
                    "first": "Nick S.",
                    "initial": "N.S.",
                    "last": "Laursen"
                },
                {
                    "first": "Peter S.",
                    "initial": "P.S.",
                    "last": "Lee"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Zakrzewska"
                },
                {
                    "first": "Liesbeth",
                    "initial": "L.",
                    "last": "Dekking"
                },
                {
                    "first": "Jeroen",
                    "initial": "J.",
                    "last": "Tolboom"
                },
                {
                    "first": "Lisanne",
                    "initial": "L.",
                    "last": "Tettero"
                },
                {
                    "first": "Sander",
                    "initial": "S.",
                    "last": "Van Meerten"
                },
                {
                    "first": "Wenli",
                    "initial": "W.",
                    "last": "Yu"
                },
                {
                    "first": "Wouter",
                    "initial": "W.",
                    "last": "Koudstaal"
                },
                {
                    "first": "Jaap",
                    "initial": "J.",
                    "last": "Goudsmit"
                },
                {
                    "first": "Andrew B.",
                    "initial": "A.B.",
                    "last": "Ward"
                },
                {
                    "first": "Wim",
                    "initial": "W.",
                    "last": "Meijberg"
                },
                {
                    "first": "Ian A.",
                    "initial": "I.A.",
                    "last": "Wilson"
                },
                {
                    "first": "Katarina",
                    "initial": "K.",
                    "last": "Rado\u0161evic"
                }
            ],
            "doi": "10.1126/science.aac7263",
            "firstpage": "1301",
            "issn": "00368075",
            "lastpage": "1306",
            "pmid": "26303961",
            "pub_year": 2015,
            "title": "A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen",
            "volume": "349"
        },
        "b0225": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1016/j.chom.2015.10.003",
            "firstpage": "395",
            "issn": "19313128",
            "lastpage": "397",
            "pmid": "26468743",
            "pub_year": 2015,
            "title": "The Quest for a Universal Flu Vaccine: Headless HA 2.0",
            "volume": "18"
        },
        "b0230": null,
        "b0235": null,
        "b0240": {
            "authors": [
                {
                    "first": "Raffael",
                    "initial": "R.",
                    "last": "Nachbagauer"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Choi"
                },
                {
                    "first": "Ariana",
                    "initial": "A.",
                    "last": "Hirsh"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Sayaka",
                    "initial": "S.",
                    "last": "Iida"
                },
                {
                    "first": "Aldo",
                    "initial": "A.",
                    "last": "Barrera"
                },
                {
                    "first": "Marcela",
                    "initial": "M.",
                    "last": "Ferres"
                },
                {
                    "first": "Randy A.",
                    "initial": "R.A.",
                    "last": "Albrecht"
                },
                {
                    "first": "Adolfo",
                    "initial": "A.",
                    "last": "Garc\u00eda-Sastre"
                },
                {
                    "first": "Nicole M.",
                    "initial": "N.M.",
                    "last": "Bouvier"
                },
                {
                    "first": "Kimihito",
                    "initial": "K.",
                    "last": "Ito"
                },
                {
                    "first": "Rafael A.",
                    "initial": "R.A.",
                    "last": "Medina"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1038/ni.3684",
            "firstpage": "464",
            "issn": "15292908",
            "lastpage": "473",
            "pmid": "28192418",
            "pub_year": 2017,
            "title": "Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins",
            "volume": "18"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Mark W.",
                    "initial": "M.W.",
                    "last": "LaMere"
                },
                {
                    "first": "Ho Tak",
                    "initial": "H.T.",
                    "last": "Lam"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Moquin"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Haynes"
                },
                {
                    "first": "Frances E.",
                    "initial": "F.E.",
                    "last": "Lund"
                },
                {
                    "first": "Troy D.",
                    "initial": "T.D.",
                    "last": "Randall"
                },
                {
                    "first": "Denise A.",
                    "initial": "D.A.",
                    "last": "Kaminski"
                }
            ],
            "doi": "10.4049/jimmunol.1003057",
            "firstpage": "4331",
            "issn": "00221767",
            "lastpage": "4339",
            "pmid": "21357542",
            "pub_year": 2011,
            "title": "Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus",
            "volume": "186"
        },
        "b0250": {
            "authors": [
                {
                    "first": "Mark W.",
                    "initial": "M.W.",
                    "last": "LaMere"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Moquin"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Eun-Hyung Lee"
                },
                {
                    "first": "Ravi S.",
                    "initial": "R.S.",
                    "last": "Misra"
                },
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Blair"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Haynes"
                },
                {
                    "first": "Troy D.",
                    "initial": "T.D.",
                    "last": "Randall"
                },
                {
                    "first": "Frances E.",
                    "initial": "F.E.",
                    "last": "Lund"
                },
                {
                    "first": "Denise A.",
                    "initial": "D.A.",
                    "last": "Kaminski"
                }
            ],
            "doi": "10.1128/JVI.00150-11",
            "firstpage": "5027",
            "issn": "0022538X",
            "lastpage": "5035",
            "pmid": "21367900",
            "pub_year": 2011,
            "title": "Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance",
            "volume": "85"
        },
        "b0255": {
            "authors": [
                {
                    "first": "Hillary A.",
                    "initial": "H.A.",
                    "last": "Vanderven"
                },
                {
                    "first": "Fernanda",
                    "initial": "F.",
                    "last": "Ana-Sosa-Batiz"
                },
                {
                    "first": "Sinthujan",
                    "initial": "S.",
                    "last": "Jegaskanda"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Rockman"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Laurie"
                },
                {
                    "first": "Ian",
                    "initial": "I.",
                    "last": "Barr"
                },
                {
                    "first": "Weisan",
                    "initial": "W.",
                    "last": "Chen"
                },
                {
                    "first": "Bruce",
                    "initial": "B.",
                    "last": "Wines"
                },
                {
                    "first": "P. Mark",
                    "initial": "P.M.",
                    "last": "Hogarth"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Matthew S.",
                    "initial": "M.S.",
                    "last": "Parsons"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Kent"
                }
            ],
            "doi": "10.1016/j.ebiom.2016.04.029",
            "firstpage": "277",
            "issn": "23523964",
            "lastpage": "290",
            "pmid": "27428437",
            "pub_year": 2016,
            "title": "What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins",
            "volume": "8"
        },
        "b0260": null,
        "b0265": {
            "authors": [
                {
                    "first": "Andrea J.",
                    "initial": "A.J.",
                    "last": "Sant"
                },
                {
                    "first": "Anthony T.",
                    "initial": "A.T.",
                    "last": "DiPiazza"
                },
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "Nayak"
                },
                {
                    "first": "Ajitanuj",
                    "initial": "A.",
                    "last": "Rattan"
                },
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Richards"
                }
            ],
            "doi": "10.1111/imr.12662",
            "firstpage": "91",
            "issn": "01052896",
            "lastpage": "105",
            "pmid": "29944766",
            "pub_year": 2018,
            "title": "CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential",
            "volume": "284"
        },
        "b0270": {
            "authors": [
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Richards"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Nayak"
                },
                {
                    "first": "Francisco A.",
                    "initial": "F.A.",
                    "last": "Chaves"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Dipiazza"
                },
                {
                    "first": "Zackery A.G.",
                    "initial": "Z.A.G.",
                    "last": "Knowlden"
                },
                {
                    "first": "Shabnam",
                    "initial": "S.",
                    "last": "Alam"
                },
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Treanor"
                },
                {
                    "first": "Andrea J.",
                    "initial": "A.J.",
                    "last": "Sant"
                }
            ],
            "doi": "10.1093/infdis/jiu662",
            "firstpage": "86",
            "issn": "00221899",
            "lastpage": "94",
            "pmid": "25492919",
            "pub_year": 2015,
            "title": "Seasonal influenza can poise hosts for CD4 T-cell immunity to H7N9 avian influenza",
            "volume": "212"
        },
        "b0275": {
            "authors": [
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "Nayak"
                },
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Richards"
                },
                {
                    "first": "Hongmei",
                    "initial": "H.",
                    "last": "Yang"
                },
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Treanor"
                },
                {
                    "first": "Andrea J.",
                    "initial": "A.J.",
                    "last": "Sant"
                }
            ],
            "doi": "10.1093/infdis/jiu616",
            "firstpage": "1408",
            "issn": "00221899",
            "lastpage": "1417",
            "pmid": "25378637",
            "pub_year": 2015,
            "title": "Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses",
            "volume": "211"
        },
        "b0280": {
            "authors": [
                {
                    "first": "Jenny Aurielle B.",
                    "initial": "J.A.B.",
                    "last": "Babon"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Cruz"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Orphin"
                },
                {
                    "first": "Pamela",
                    "initial": "P.",
                    "last": "Pazoles"
                },
                {
                    "first": "Mary Dawn T.",
                    "initial": "M.D.T.",
                    "last": "Co"
                },
                {
                    "first": "Francis A.",
                    "initial": "F.A.",
                    "last": "Ennis"
                },
                {
                    "first": "Masanori",
                    "initial": "M.",
                    "last": "Terajima"
                }
            ],
            "doi": "10.1016/j.humimm.2009.06.004",
            "firstpage": "711",
            "issn": "01988859",
            "lastpage": "721",
            "pmid": "19524006",
            "pub_year": 2009,
            "title": "Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4+ T-cell responses to internal proteins, hemagglutinins, and neuraminidases",
            "volume": "70"
        }
    },
    "body_text": [
        {
            "endOffset": 25694,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "As stated above, three mice per vaccination group per challenge dose were used.",
            "startOffset": 25615,
            "title": "Animal experiments"
        },
        {
            "endOffset": 21364,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "BTI-TN-5B1-4 (High Five) cells for protein expression were grown in serum-free SFX medium (HyClone) supplemented with penicillin-streptomycin solution.",
            "startOffset": 21213,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 26544,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Four weeks after the initial boost, these mice were boosted IM with 5 \u00b5g of recombinant cH4/3 protein adjuvanted with 5 \u03bcg of polyI:C (Sigma-Aldrich) in 50 \u00b5L of PBS.",
            "startOffset": 26378,
            "title": "Animal experiments"
        },
        {
            "endOffset": 44314,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "To assess the humoral immune response to vaccination we performed ELISAs with pre-challenge serum (from mice vaccinated as shown in Fig. 2A), against a panel of group 2 HA recombinant proteins (Fig. 4A).",
            "startOffset": 44111,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 53391,
            "parents": [],
            "secId": "s0095",
            "sentence": "We also found high reactivity of antibodies to recombinant NP and M1 protein in all animals vaccinated with viral vectors expressing the NP+M1 fusion protein.",
            "startOffset": 53233,
            "title": "Discussion"
        },
        {
            "endOffset": 24818,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "In VV NP+M1, mice received a prime and a boost of ChAdOx1 NP+M1 and MVA-NP+M1, respectively, 3 weeks apart.",
            "startOffset": 24711,
            "title": "Animal experiments"
        },
        {
            "endOffset": 30833,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After the PBS wash, 6.25 \u00d7 104 Fc\u03b3RIIa reporter cells (in 25 \u00b5L) (Promega), 25 \u00b5L of 1XMEM and 25 \u00b5L of diluted sera were added to the MDCK cells.",
            "startOffset": 30687,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 42957,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "There was no difference between these groups in terms of weight loss (all approx. 15%) suggesting that combining strategies did not add a benefit to protection afforded with vaccination against NP+M1 alone.",
            "startOffset": 42751,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 19358,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore, and because group 2 viruses like H3N2 cause high morbidity and mortality in humans, work on a group 2 vaccine component is important.",
            "startOffset": 19214,
            "title": "Introduction"
        },
        {
            "endOffset": 38351,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "This was not performed for H7N9 due to unavailability of sufficient GFP expressing vectors at the time.",
            "startOffset": 38248,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 52201,
            "parents": [],
            "secId": "s0095",
            "sentence": "For H3N2 challenge both the cHA only and the NP+M1 only vaccination provided protection but combining the approach clearly led to an increase in protection as evidenced by minimal weight loss (morbidity) and complete survival.",
            "startOffset": 51975,
            "title": "Discussion"
        },
        {
            "endOffset": 52913,
            "parents": [],
            "secId": "s0095",
            "sentence": "Humans have low levels of pre-existing anti-group 2 stalk immunity and are therefore primed already.",
            "startOffset": 52813,
            "title": "Discussion"
        },
        {
            "endOffset": 43748,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Antibody titers in the shared groups were similar in both experiments (Fig. 4A and Suppl. Fig. 4).",
            "startOffset": 43650,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 18519,
            "parents": [],
            "secId": "s0005",
            "sentence": "Although these avian head domains are immunogenic, the overall response is predominantly against the seasonal HA stalk domains given that humans have not encountered these avian viruses in circulation previously and are therefore not primed.",
            "startOffset": 18278,
            "title": "Introduction"
        },
        {
            "endOffset": 38037,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Prior to assessing the protective efficacy of bivalent viral vector vaccination (expressing cHAs and NP+M1) in mice, a dose titration of group 2 challenge viruses was carried out.",
            "startOffset": 37858,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 29793,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "A cutoff value of the average of the OD values of blank wells plus three standard deviations was established for each plate and used for calculating the area under the curve (AUC), which was the readout for this assay.",
            "startOffset": 29575,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 39363,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "We determined the optimal challenge doses as 102 pfu/mouse for A/Philippines/2/82 (H3N2), 104 pfu/mouse for A/Shanghai/1/2013 (H7N9), and 2 \u00d7 103 pfu/mouse for A/Jiangxi-Donghu/346/2013 (H10N8).",
            "startOffset": 39169,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 35576,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "The data was presented as individual replicates or means with standard deviation (SD); n represents the number of mice per experiment.",
            "startOffset": 35442,
            "title": "Statistics"
        },
        {
            "endOffset": 43307,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 43306,
                    "startOffset": 43302
                }
            },
            "secId": "s0080",
            "sentence": "Since cHA vaccination had provided 100% protection from H7N9 challenge with a slightly different vaccination regimen (cHA DNA followed by two recombinant protein vaccinations [11]), we also added a bridging group (\u2018cHA and Full Length H3\u2032) to asses if the cHA vectored approach was inferior to the DNA-prime/protein boost approach used earlier [11].",
            "startOffset": 42958,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 34131,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The plates were incubated for 18 h at 37 \u00b0C and then washed 5 times with PBS.",
            "startOffset": 34054,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 38536,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Six weeks post-boost, groups of mice were challenged with log incremental titers of A/Philippines/2/82 (H3N2), A/Shanghai/1/2013 (H7N9) and A/Jiangxi-Donghu/346/2013 (H10N8) (Fig. 1A).",
            "startOffset": 38352,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 41352,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Groups receiving combinations of viral vectors expressing NP+M1 and cHA outperformed other vaccinated groups showing minimal weight loss post challenge.",
            "startOffset": 41200,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 44755,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "ELISA titers of animals that experienced cHAs twice (VV cHA-NP+M1 Late and Early) were four-fold lower.",
            "startOffset": 44652,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 33943,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The immunodominant H-2Kd \u2013restricted (BALB/c) NP147\u2013155 (TYQRTRALV) epitope was used to measure immunodominant IFN\u03b3 responses towards the NP (4).",
            "startOffset": 33798,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 35825,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "All statistical analyses were performed using GraphPad Prism 7 for Windows.",
            "startOffset": 35750,
            "title": "Statistics"
        },
        {
            "endOffset": 27568,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Mock Control group mice were primed IM with 5 \u00b5g of bovine serum albumin (BSA) adjuvanted with 5 \u00b5g polyI:C.",
            "startOffset": 27460,
            "title": "Animal experiments"
        },
        {
            "endOffset": 47902,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "The majority of detected cells in VV NP+M1, VV cHA-NP+M1 Late, and VV cHA-NP+M1 Early groups were polyfunctional and expressed both IFN\u03b3 and TNF\u03b1, fewer cells expressed only IFN\u03b3 and a small percentage expressed IFN\u03b3, TNF\u03b1 and IL-2.",
            "startOffset": 47670,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 31278,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The cutoff was defined as the average of the values of the blank wells plus 5 times the standard deviation of the blank wells.",
            "startOffset": 31152,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 29488,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "After 10 min of incubation at RT, the reaction was stopped by adding 50 \u00b5L of 3 M HCl (Fisher Scientific) to the mixture.",
            "startOffset": 29367,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 28040,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Six weeks after the final boost, mice were intranasally (IN) infected with a lethal dose of A/Philippines/2/82 (H3N2), A/Shanghai/1/13 (H7N9) or A/Jiangxi-Donghu/346/13 (H10N8) (all 6:2 A/PR/8/34 reassortants) and weight loss was measured for a 14-day period.",
            "startOffset": 27781,
            "title": "Animal experiments"
        },
        {
            "endOffset": 32643,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "To the original plate containing serum dilutions, 60 \u00b5L of infection media was added to reconstitute the volume to 120 \u00b5L.",
            "startOffset": 32521,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 38870,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "This was performed to identify a challenge dose that would induce significant weight loss in mice vaccinated with NP+M1-expressing vectors but would be lethal in animals vaccinated with vectors expressing GFP to ensure we could adequately monitor any combined protective efficacy post-vaccination with both cHA and NP+M1 (Fig. 1B-D).",
            "startOffset": 38537,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 24532,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "All experiments were performed in accordance with protocols approved by the Icahn School of Medicine at Mount Sinai Institutional Animal Care and Use Committee (IACUC).",
            "startOffset": 24364,
            "title": "Animal experiments"
        },
        {
            "endOffset": 48030,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Responses were strongest in the VV cHA-NP+M1 Late group followed by VV NP+M1 and VV cHA-NP+M1 Early groups, which were similar.",
            "startOffset": 47903,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 25549,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The survival and weight loss was monitored over 14 days, with a 25% weight loss cut-off used as a humane end point following which mice were euthanized.",
            "startOffset": 25397,
            "title": "Animal experiments"
        },
        {
            "endOffset": 49783,
            "parents": [],
            "secId": "s0095",
            "sentence": "Although one vector might be sufficient, multiple studies using the ChAdOx1 \u2013 MVA prime boost regimen for a variety of viral glycoproteins have shown to be superior to a singular vector prime.",
            "startOffset": 49591,
            "title": "Discussion"
        },
        {
            "endOffset": 22747,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 22746,
                    "startOffset": 22739
                },
                "b0185": {
                    "endOffset": 22746,
                    "startOffset": 22739
                }
            },
            "secId": "s0020",
            "sentence": "Soluble A/Philippines/2/82 H3, A/Shanghai/1/13 H7 and A/Jiangxi-Donghu/346/13 H10 HA containing a T4 foldon trimerization domain and a C-terminal hexahistidine tag for purification were generated using the baculovirus protein expression system as previously described [36,37].",
            "startOffset": 22471,
            "title": "Recombinant proteins"
        },
        {
            "endOffset": 35082,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Briefly, splenocytes were stimulated in a 96-well round bottom plate (Falcon) with the peptides or peptide arrays (described above) at a final concentration of 1 \u00b5g/mL in the presence of Brefeldin-A (BioLegend) at 37 \u00b0C.",
            "startOffset": 34862,
            "title": "Intracellular cytokine staining (ICS) assay"
        },
        {
            "endOffset": 19913,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 19808,
                    "startOffset": 19801
                },
                "b0095": {
                    "endOffset": 19808,
                    "startOffset": 19801
                },
                "b0100": {
                    "endOffset": 19808,
                    "startOffset": 19801
                },
                "b0105": {
                    "endOffset": 19912,
                    "startOffset": 19905
                },
                "b0110": {
                    "endOffset": 19912,
                    "startOffset": 19905
                },
                "b0115": {
                    "endOffset": 19912,
                    "startOffset": 19905
                },
                "b0120": {
                    "endOffset": 19912,
                    "startOffset": 19905
                },
                "b0125": {
                    "endOffset": 19912,
                    "startOffset": 19905
                }
            },
            "secId": "s0005",
            "sentence": "It has been shown that T-cell responses targeting these epitopes can be highly protective in the mouse model [18\u201320] and both CD8+ and CD4+ T-cells correlate with protection in humans, also in elderly populations [21\u201325].",
            "startOffset": 19692,
            "title": "Introduction"
        },
        {
            "endOffset": 28900,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "After blocking, pre-diluted serum was added to the first well to a final concentration of 1:100 in blocking solution.",
            "startOffset": 28783,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 29975,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "MDCK cells were seeded at a concentration of 2 \u00d7 105 cells/well in white polystyrene 96-well plates (Costar Corning).",
            "startOffset": 29858,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 41762,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Mice in the VV NP+M1 group underwent faster initial weight loss until day 3 post challenge than all other groups but started to regain weight by day 5 and were completely protected from mortality.",
            "startOffset": 41566,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 32753,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Hundred \u00b5l of the serum dilutions were transferred onto the cells, and they were incubated at 37 \u00b0C for 48 h.",
            "startOffset": 32644,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 51591,
            "parents": [],
            "secId": "s0095",
            "sentence": "Importantly, these viruses only carry the HA and neuraminidase of the respective wild type viruses, their other six genomic segments are derived from H1N1 strain A/PR/8/34.",
            "startOffset": 51419,
            "title": "Discussion"
        },
        {
            "endOffset": 39168,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The corresponding Kaplan-Meier survival plots are shown (Fig. S2).",
            "startOffset": 39102,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 50055,
            "parents": [],
            "secId": "s0095",
            "sentence": "Our data suggests that T cell responses in mice vaccinated with the bivalent viral vectors induce robust cellular immune responses.",
            "startOffset": 49924,
            "title": "Discussion"
        },
        {
            "endOffset": 39540,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Using these challenge doses, the increase in protective efficacy with bivalent over monovalent viral vectors can be efficiently assessed with an abrogation of this weight loss.",
            "startOffset": 39364,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 18883,
            "parents": [],
            "secId": "s0005",
            "sentence": "So far, the cHA concept has been tested widely for group 1 HAs but relatively little work has been performed with group 2 HAs.",
            "startOffset": 18757,
            "title": "Introduction"
        },
        {
            "endOffset": 41565,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The benefits of combining approaches were present but less pronounced for H10N8 challenged mice.",
            "startOffset": 41469,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 53086,
            "parents": [],
            "secId": "s0095",
            "sentence": "Giving two vectored vaccines would therefore resemble a prime-boost-boost regimen in a na\u00efve animal model and would likely boost cross-reactive antibodies very efficiently.",
            "startOffset": 52914,
            "title": "Discussion"
        },
        {
            "endOffset": 21606,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Madin Darby Canine Kidney (MDCK) cells were grown in Dulbecco\u2019s Modified Eagle\u2019s Medium (DMEM) supplemented with 5% FBS, penicillin-streptomycin solution and 5% 1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) solution (Gibco).",
            "startOffset": 21365,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 30365,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The following day, the cells were washed with PBS and 100 \u03bcL of H3N2 A/Philippines/2/82 (6:2 A/PR/8/34 reassortant) at a multiplicity of infection of 1 in 1 \u00d7 minimum essential medium (MEM) (10% 10 X MEM (Gibco), 1% 200 mM L-glutamine (Gibco), 1.6% of sodium bicarbonate stock solution (Sigma-Aldrich), 1% stock solution HEPES (Gibco) and 1% penicillin-streptomycin was added to each well.",
            "startOffset": 29976,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 25614,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "For H7N9, only the ChAdOx1 NP+M1 and MVA-NP+M1 group was tested.",
            "startOffset": 25550,
            "title": "Animal experiments"
        },
        {
            "endOffset": 34053,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Medium alone was used as a negative control.",
            "startOffset": 34009,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 30606,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The following day, pre-challenge mouse serum was serially diluted (with a starting concentration of 1:10) 2-fold in RPMI 1640 medium (Life Technologies) in a separate 96-well plate.",
            "startOffset": 30425,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 30945,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After a 6-hour incubation at 37 \u00b0C, 75 \u00b5L of the Bio-Glo luciferase substrate (Promega) was added to each well.",
            "startOffset": 30834,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 45481,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "However, we found that a robust cross-reactive response required three immunizations with cHA antigen as antibodies induced in VV cHA-NP+M1 Late and Early groups were not as cross-reactive as the antibodies induced in the VV cHA with cHA Boost vaccination regimen.",
            "startOffset": 45217,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 24042,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The bivalent expression construct was made by inserting the NP-M1 under F11 control followed immediately by the cH15/3 under mH5 control within the F11 insertion site.",
            "startOffset": 23875,
            "title": "Viral vectors"
        },
        {
            "endOffset": 55088,
            "parents": [],
            "secId": "s0095",
            "sentence": "Overall, these results improve our understanding of vaccination platforms capable of harnessing cellular and humoral immunity with the ultimate goal of designing a universal influenza virus vaccine.",
            "startOffset": 54890,
            "title": "Discussion"
        },
        {
            "endOffset": 21909,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The influenza A virus strains A/Philippines/2/82 (H3N2, X-79), A/Shanghai/1/13 (H7N9) and A/Jiangxi-Donghu/346/13 (H10N8) were all reassortants carrying the internal genes from vaccine strain A/PR/8/34 (PR8; H1N1) and were grown in 10-day-old embryonated chicken eggs (Charles River) for 48 h at 37 \u00b0C.",
            "startOffset": 21607,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 17383,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 17382,
                    "startOffset": 17377
                },
                "b0015": {
                    "endOffset": 17382,
                    "startOffset": 17377
                }
            },
            "secId": "s0005",
            "sentence": "Mismatches between vaccine strains and circulating strains frequently occur, leading to a sharp decline in vaccine effectiveness [2,3].",
            "startOffset": 17248,
            "title": "Introduction"
        },
        {
            "endOffset": 51657,
            "parents": [],
            "secId": "s0095",
            "sentence": "This makes them pathogenic for mice (A/PR/8/34 is mouse adapted).",
            "startOffset": 51592,
            "title": "Discussion"
        },
        {
            "endOffset": 33024,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "A classical hemagglutination assay was used as a readout wherein 50 \u00b5L of the supernatant from the cells was incubated at 4 \u00b0C for one hour with 50 \u00b5L of 0.5% chicken red blood cells (RBCs, Lampire Biological Laboratories) in PBS in a 96-well V-bottomed plate (Corning).",
            "startOffset": 32754,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 48928,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "To summarize, these results suggest that vectored vaccines can simultaneously induce cellular and humoral immune responses to multiple influenza virus antigens, which may lead to broad, long-lasting protection against influenza viruses.",
            "startOffset": 48692,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 43649,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Of note, these results are pooled from two separate experiments with the VV cHA with cHA, VV cHA-NP+M1 Early and Na\u00efve groups being present in both.",
            "startOffset": 43501,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 27351,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "For the H7N9 experiment, an additional group was added to bridge to a previously published study.",
            "startOffset": 27254,
            "title": "Animal experiments"
        },
        {
            "endOffset": 34390,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The plates were then washed 5 times with PBS and the streptavidin-alkaline phosphatase was added and the plates were incubated for 1 h at room temperature.",
            "startOffset": 34235,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 41039,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "However, mice receiving cHA vaccines only or NP-M1 only (in VV cHA with cHA Boost and VV NP+M1, respectively) showed considerable weight loss with one mouse succumbing to infection in the VV NP+M1 group.",
            "startOffset": 40836,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 47592,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Using the ELISpot assay, we found increased numbers of influenza virus-specific IFN\u03b3 expressing cells following stimulation with the NP147-155 immunodominant peptide (Fig. 5A) in mice that received monovalent or bivalent viral vectors expressing the NP+M1 fusion protein (VV NP+M1, VV cHA-NP+M1 Late, and VV cHA-NP+M1 Early).",
            "startOffset": 47267,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 51081,
            "parents": [],
            "secId": "s0095",
            "sentence": "However, H3N2 is currently the subtype that causes most morbidity and mortality in humans and both H7N9 and H10N8 have caused zoonotic infections.",
            "startOffset": 50935,
            "title": "Discussion"
        },
        {
            "endOffset": 51974,
            "parents": [],
            "secId": "s0095",
            "sentence": "Challenge doses were initially titrated, selecting a dose that induced significant weight loss in the NP+M1 vector-vaccinated animals.",
            "startOffset": 51840,
            "title": "Discussion"
        },
        {
            "endOffset": 33549,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Spleens were then pushed through a 70 \u00b5M filter (Foxx Life Sciences) to create single-cell suspensions in minimum essential medium eagle with alpha modification (alpha MEM) (Sigma-Aldrich) supplemented with 5% FBS and penicillin-streptomycin solution.",
            "startOffset": 33298,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 44494,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "VV cHA with cHA Boost, VV cHA-NP+M1 Late, and VV cHA-NP+M1 Early groups vaccinated with cHA expressing viral vectors showed high levels of H3-reactive antibodies post-vaccination.",
            "startOffset": 44315,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 16729,
            "parents": [],
            "secId": "s0005",
            "sentence": "The protection conferred is restricted to seasonal influenza virus, and does not cover emerging pandemic influenza virus strains.",
            "startOffset": 16600,
            "title": "Introduction"
        },
        {
            "endOffset": 31444,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "MDCK cells (2 \u00d7 105 cells/ml) were seeded at 100 \u00b5L/well in 96-well cell culture plates (Costar Corning), and incubated for 12 h at 37 \u00b0C.",
            "startOffset": 31306,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 33297,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Spleens were aseptically removed from vaccinated mice three weeks after the second IM boost.",
            "startOffset": 33205,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 21988,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Eggs were then cooled overnight at 4 \u00b0C before harvesting the allantoic fluid.",
            "startOffset": 21910,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 40656,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The VV Control, Mock Control, and Na\u00efve groups were vaccinated with GFP-expressing vectors, irrelevant recombinant protein with adjuvant or were completely na\u00efve, respectively.",
            "startOffset": 40480,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 54368,
            "parents": [],
            "refoffsets": {
                "b0260": {
                    "endOffset": 54289,
                    "startOffset": 54285
                }
            },
            "secId": "s0095",
            "sentence": "In addition, T-cells targeting conserved epitopes of the HA [52] might also contribute to protection but have not been evaluated in this study.",
            "startOffset": 54225,
            "title": "Discussion"
        },
        {
            "endOffset": 31648,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Pooled sera were treated with receptor destroying enzyme (RDE; Denka Seiken) as per manufacturer\u2019s instructions (1:3 ratio).",
            "startOffset": 31524,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 51839,
            "parents": [],
            "secId": "s0095",
            "sentence": "Of note, the NP and M1 expressed by the viral vectors tested are derived from recent H3N2 isolates and therefore are heterologous to the NP and M1 proteins of the challenge viruses.",
            "startOffset": 51658,
            "title": "Discussion"
        },
        {
            "endOffset": 42111,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Vectored cHA vaccination (VV cHA with cHA Boost) protected most mice well from severe weight loss but one mouse succumbed to infection.",
            "startOffset": 41976,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 20387,
            "parents": [],
            "secId": "s0005",
            "sentence": "These vectors induced strong humoral and cellular responses against all three antigens.",
            "startOffset": 20300,
            "title": "Introduction"
        },
        {
            "endOffset": 53987,
            "parents": [],
            "secId": "s0095",
            "sentence": "When measured in an H3N2 ADCC reporter assay, sera from groups vaccinated with cHA expressing vectors showed high activity \u2013 likely the main protective mechanism for stalk antibodies (neutralization was not observed in this study).",
            "startOffset": 53756,
            "title": "Discussion"
        },
        {
            "endOffset": 22071,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The allantoic fluid was centrifuged at 2000 g for 10 min at 4 \u00b0C to remove debris.",
            "startOffset": 21989,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 46365,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "To test whether the induced antibodies can induce Fc effector functions such as antibody-dependent cellular cytotoxicity, pooled sera were assayed in an in vitro ADCC reporter assay.",
            "startOffset": 46183,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 16878,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 16877,
                    "startOffset": 16874
                }
            },
            "secId": "s0005",
            "sentence": "Current seasonal influenza virus vaccines induce antibody responses against the hemagglutinin (HA), the major surface glycoprotein of the virus [1].",
            "startOffset": 16730,
            "title": "Introduction"
        },
        {
            "endOffset": 48371,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In this case, the VV NP+M1 group showed the strongest signal in ELISpot while VV NP+M1, VV cHA-NP+M1 Late, and VV cHA-NP+M1 Early groups were similar in ICS.",
            "startOffset": 48214,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 31863,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The solution was reconstituted to a final serum concentration of 10% with PBS.",
            "startOffset": 31785,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 25396,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Both groups were then challenged intranasaly (IN) with log incremental doses of A/Philippines/2/82 (H3N2, X-79), A/Shanghai/1/13 (H7N9) or A/Jiangxi-Donghu/346/13 (H10N8) (all 6:2 A/PR/8/34 reassortants).",
            "startOffset": 25192,
            "title": "Animal experiments"
        },
        {
            "endOffset": 50776,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 50775,
                    "startOffset": 50772
                }
            },
            "secId": "s0095",
            "sentence": "Immune responses to the stalk domain are typically group-specific and either target group 1 (H1, H2, H5, H6, H8, H9, H11, H12, H13, H16, H17 and H18) or group 2 (H3, H4, H7, H10, H14, and H15), with exceptions on the monoclonal level [1].",
            "startOffset": 50538,
            "title": "Discussion"
        },
        {
            "endOffset": 32108,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Samples were assayed in triplicates, starting at a dilution of 1:25, and serially diluted 2-fold in infection media (UltraMDCK media (Lonza) with N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) \u2013 treated trypsin) to a final volume of 120 \u00b5L.",
            "startOffset": 31864,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 40479,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "This approach was taken to test if a longer interval between the last vaccination and challenge would negatively impact on the protective effect of the vaccine.",
            "startOffset": 40319,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 47266,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "We harvested splenocytes three weeks after the final boost and stimulated these cells with the BALB/c restricted immunodominant NP147-155 epitope.",
            "startOffset": 47120,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 20896,
            "parents": [],
            "secId": "s0005",
            "sentence": "Overall, our findings suggest that combining the two different vaccine approaches leads to enhanced protection in vivo.",
            "startOffset": 20777,
            "title": "Introduction"
        },
        {
            "endOffset": 27780,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "At 4 and 8 weeks after the prime, mice in the Mock Control group were boosted IM with 5 \u00b5g of BSA adjuvanted with 5 \u00b5g polyI:C. Na\u00efve group mice were na\u00efve controls and received no vaccination at any time point.",
            "startOffset": 27569,
            "title": "Animal experiments"
        },
        {
            "endOffset": 34571,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The plates were washed as above and the IFN\u03b3 secreting cells were detected using the alkaline phosphatase conjugate substrate kit (Bio-Rad), as per the manufacturer\u2019s instructions.",
            "startOffset": 34391,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 53543,
            "parents": [],
            "secId": "s0095",
            "sentence": "These antibodies, due to the internal nature of their targets, likely have difficulties to interact with NP and M1 in intact virions or infected cells.",
            "startOffset": 53392,
            "title": "Discussion"
        },
        {
            "endOffset": 24953,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Mice in the VV Control group received the corresponding ChAdOx1 and MVA green fluorescent protein (GFP) control vectors 3 weeks apart.",
            "startOffset": 24819,
            "title": "Animal experiments"
        },
        {
            "endOffset": 24363,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Six to eight week old female BALB/c mice (Jackson Laboratories) were used for all animal experiments.",
            "startOffset": 24262,
            "title": "Animal experiments"
        },
        {
            "endOffset": 22225,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For virus purification, viruses were grown as described above (including the low-speed centrifugation step).",
            "startOffset": 22117,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 48572,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "For CD4+T-cells, the responses observed in the VV NP+M1 and VV cHA-NP+M1 Early groups were similar.",
            "startOffset": 48473,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 52335,
            "parents": [],
            "secId": "s0095",
            "sentence": "The benefits could also be seen, although to a lesser degree, in H10N8 challenged animals and were absent in H7N9 challenged animals.",
            "startOffset": 52202,
            "title": "Discussion"
        },
        {
            "endOffset": 23517,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 23416,
                    "startOffset": 23413
                },
                "b0150": {
                    "endOffset": 23516,
                    "startOffset": 23512
                }
            },
            "secId": "s0025",
            "sentence": "For monovalent vaccines cH14/3 (head domain from A/mallard/Gurjev/263/1982 (H14N5) plus stalk domain from A/Perth/16/09 (H3N2)) [9] or NP+M1 (from H3N2 strain A/Panama/2007/1999, joined by a 7 amino acid linker) were expressed [30].",
            "startOffset": 23285,
            "title": "Viral vectors"
        },
        {
            "endOffset": 49369,
            "parents": [],
            "secId": "s0095",
            "sentence": "This was achieved by co-expression of an NP+M1 fusion protein and different cHAs using ChAdOx1 and MVA replication deficient vectors.",
            "startOffset": 49236,
            "title": "Discussion"
        },
        {
            "endOffset": 35428,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "ICS results are expressed as % of CD8+ T cells.",
            "startOffset": 35381,
            "title": "Intracellular cytokine staining (ICS) assay"
        },
        {
            "endOffset": 40835,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Following IN challenge with H3N2, VV cHA with cHA Boost, VV cHA-NP+M1 Late, and VV cHA-NP+M1 Early groups (all expressing cHAs) were completely protected from mortality (Fig. 2B).",
            "startOffset": 40656,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 36524,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Based on previous studies, a vector vaccination order of ChAdOx1 followed by MVA shows the strongest immune response induction, and will be consistently applied in this study.",
            "startOffset": 36349,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 48691,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "The overall induction of CD4+T-cells was low and cells expressing only IFN\u03b3 were the predominant population (Fig. 5C).",
            "startOffset": 48573,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 23874,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 23857,
                    "startOffset": 23854
                },
                "b0190": {
                    "endOffset": 23643,
                    "startOffset": 23639
                },
                "b0195": {
                    "endOffset": 23692,
                    "startOffset": 23688
                },
                "b0200": {
                    "endOffset": 23728,
                    "startOffset": 23724
                }
            },
            "secId": "s0025",
            "sentence": "Expression from the MVA vectors [38] was driven using an endogenous F11 promoter [39] for NP+M1 and the mH5 promotor [40] for cH15/3 (head domain from A/shearwater/Western Australia/2576/1979 (H15N9) plus stalk domain from A/Perth/16/2009 (H3N2)) [9] at the F11 site.",
            "startOffset": 23607,
            "title": "Viral vectors"
        },
        {
            "endOffset": 25191,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The vaccinations were administered intramuscularly (IM) at 1x108 infectious units (IU)/50 \u00b5L in phosphate buffered saline (PBS) for the chimpanzee adenovirus vectors, and 1x106 plaque forming units (pfu)/50 \u00b5L in PBS for the MVA vectors.",
            "startOffset": 24954,
            "title": "Animal experiments"
        },
        {
            "endOffset": 44651,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Mice in VV cHA with cHA Boost group were exposed to the H3 stalk three times including a recombinant protein boost, and showed the highest reactivity to H3.",
            "startOffset": 44495,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 22900,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "NP and M1 from A/PR/8/34 with N-terminal hexahistidine tags were expressed using the baculovirus system as well and were purified from Sf9 cell lysates.",
            "startOffset": 22748,
            "title": "Recombinant proteins"
        },
        {
            "endOffset": 54889,
            "parents": [],
            "secId": "s0095",
            "sentence": "In summary, our data shows that vaccination with cHA, NP, and M1 delivered by ChAdOx1 and MVA viral-vectored vaccines induces potent T and B cell responses which can confer broad protection in a rigorous challenge model.",
            "startOffset": 54669,
            "title": "Discussion"
        },
        {
            "endOffset": 29574,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The optical density (OD) was measured at 490 nm on a Synergy 4 plate reader (BioTek).",
            "startOffset": 29489,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 37202,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "A primary and secondary boost of ChAdOx1 cH14/3 followed by MVA-cH15/3 led to lower weight loss in mice, relative to a sequence of ChAdOx1 cH15/3 and MVA-cH14/3.",
            "startOffset": 37041,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 20145,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 20144,
                    "startOffset": 20137
                },
                "b0135": {
                    "endOffset": 20144,
                    "startOffset": 20137
                },
                "b0140": {
                    "endOffset": 20144,
                    "startOffset": 20137
                },
                "b0145": {
                    "endOffset": 20144,
                    "startOffset": 20137
                },
                "b0150": {
                    "endOffset": 20144,
                    "startOffset": 20137
                },
                "b0155": {
                    "endOffset": 20144,
                    "startOffset": 20137
                },
                "b0160": {
                    "endOffset": 20144,
                    "startOffset": 20137
                },
                "b0165": {
                    "endOffset": 20144,
                    "startOffset": 20137
                }
            },
            "secId": "s0005",
            "sentence": "To optimally induce targeted T-cell responses, NP and M1 need to be expressed intracellularly, e.g. using replication deficient viral vectors like Chimpanzee Adenovirus Oxford 1 (ChAdOx1) and Modified Vaccinia Ankara (MVA) [26\u201333].",
            "startOffset": 19914,
            "title": "Introduction"
        },
        {
            "endOffset": 28312,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The H7N9 challenge was conducted in two independent experiments with the VV cHA with cHA, VV cHA-NP+M1 Early and Na\u00efve groups being present in both.",
            "startOffset": 28164,
            "title": "Animal experiments"
        },
        {
            "endOffset": 33797,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "These plates had been previously coated with the IFN\u03b3 specific mAb overnight at 4 \u00b0C at 5 \u00b5g/mL.",
            "startOffset": 33701,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 45216,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Antibody titers against other group 2 influenza HAs such as H7 and H10 HAs showed that a broadly cross-reactive response can be obtained through the vectored cHA vaccination strategy (cH14/3, cH15/3, cH4/3).",
            "startOffset": 45009,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 50329,
            "parents": [],
            "secId": "s0095",
            "sentence": "Importantly, as demonstrated by very similar protection afforded by the two different VV cHA-NP+M1 groups (Early and Late), the induced T cell responses by these vectors seem also durable, at least in the observed time frame (6 weeks post boost versus 10 weeks post boost).",
            "startOffset": 50056,
            "title": "Discussion"
        },
        {
            "endOffset": 20727,
            "parents": [],
            "secId": "s0005",
            "sentence": "In this study, we combined these two concepts using ChAdOx1 and MVA vectors expressing group 2 cHAs and NP+M1 from the same viral vector and determined the protective effect against group 2 HA expressing viruses in a mouse model.",
            "startOffset": 20498,
            "title": "Introduction"
        },
        {
            "endOffset": 17701,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 17700,
                    "startOffset": 17695
                },
                "b0025": {
                    "endOffset": 17700,
                    "startOffset": 17695
                }
            },
            "secId": "s0005",
            "sentence": "Recent approaches to develop a universal influenza virus vaccine involve refocusing the immune response away from the globular head domain, towards the immunosubdominant, but conserved stalk region of the HA or to internal proteins like the nucleoprotein or the matrix protein 1 which are also highly conserved [4,5].",
            "startOffset": 17384,
            "title": "Introduction"
        },
        {
            "endOffset": 37040,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Overall, we observe that mice vaccinated with a DNA prime, ChAdOx1 cH14/3, and MVA-cH15/3 intramuscularly showed reduced weight loss and were completely protected from an X-31 challenge, specifically in comparison to groups that received the corresponding recombinant proteins (Fig. S1B).",
            "startOffset": 36752,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 19213,
            "parents": [],
            "secId": "s0005",
            "sentence": "The majority of isolated human anti-stalk antibodies react to either group 1 (H1, H2, H5, H6, H8, H9, H11, H12, H13, H16, H17 and H18) or group 2 (H3, H4, H7, H10, H14, H15) HAs but do not cross-react between groups; suggesting that both a group 1 and a group 2 component for a universal influenza virus vaccine will be required.",
            "startOffset": 18884,
            "title": "Introduction"
        },
        {
            "endOffset": 25943,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "One mouse in this group was pre-emptively sacrificed prior to the 25% weight loss cut off and was excluded from the study.",
            "startOffset": 25821,
            "title": "Animal experiments"
        },
        {
            "endOffset": 54224,
            "parents": [],
            "secId": "s0095",
            "sentence": "The relevance of anti-NP and anti-M1 antibodies, in addition to strong CD8+ T-cell responses against the same proteins, remains therefore unclear.",
            "startOffset": 54078,
            "title": "Discussion"
        },
        {
            "endOffset": 34739,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Results are expressed as spot forming units (SFU) per million splenocytes, calculated by subtracting the mean negative control response from the mean of each response.",
            "startOffset": 34572,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 26155,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "For experiments to assess the protective effects of monovalent (cHA or NP+M1) and bivalent (cHA-NP+M1) viral vectors against influenza virus infection, the mice were divided in to 7 experimental groups (Fig. 2A).",
            "startOffset": 25943,
            "title": "Animal experiments"
        },
        {
            "endOffset": 28567,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "ELISA plates (Immulon 4HBX; Thermo Scientific) were coated with 2 \u00b5g/mL of recombinant protein or 5 \u00b5g/mL of purified virus (50 \u00b5L per well) in coating buffer (KPL coating solution, Sera Care) at 4 \u00b0C overnight.",
            "startOffset": 28356,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 41469,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The morbidity and mortality seen in the control groups (VV Control, Mock Control, and Na\u00efve) were high, as expected.",
            "startOffset": 41353,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 36751,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Four weeks post MVA boost, the mice were challenged with 5x 50% lethal doses (LD50) of X-31 (H3N2; HA and NA from A/Hong Kong/1/1968 in an A/Puerto Rico/8/1934 backbone), and weight loss and survival was observed over 14 days.",
            "startOffset": 36525,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 37793,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Since this unspecific background makes challenge studies impossible, IM vaccination was finalized as the route of administration for future experiments to clearly delineate immune responses specific to the influenza virus antigens encoded by viral vectors.",
            "startOffset": 37537,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 31151,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The results were analyzed in GraphPad Prism 10, and the AUC values were determined.",
            "startOffset": 31068,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 17247,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, most of the antigenic drift is mediated by the very plastic globular head domain making annual re-formulation and re-administration of the vaccine necessary.",
            "startOffset": 17081,
            "title": "Introduction"
        },
        {
            "endOffset": 48213,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Increases were also observed when splenocytes were stimulated with pooled peptides spanning the entire NP+M1 fusion polypeptide and analyzed in IFN\u03b3 ELISpot and ICS assays (Fig. 5B).",
            "startOffset": 48031,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 18756,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 18686,
                    "startOffset": 18680
                },
                "b0040": {
                    "endOffset": 18686,
                    "startOffset": 18680
                },
                "b0045": {
                    "endOffset": 18686,
                    "startOffset": 18680
                },
                "b0050": {
                    "endOffset": 18686,
                    "startOffset": 18680
                },
                "b0055": {
                    "endOffset": 18686,
                    "startOffset": 18680
                },
                "b0060": {
                    "endOffset": 18686,
                    "startOffset": 18680
                },
                "b0065": {
                    "endOffset": 18686,
                    "startOffset": 18680
                },
                "b0070": {
                    "endOffset": 18686,
                    "startOffset": 18680
                },
                "b0075": {
                    "endOffset": 18755,
                    "startOffset": 18748
                },
                "b0080": {
                    "endOffset": 18755,
                    "startOffset": 18748
                },
                "b0085": {
                    "endOffset": 18755,
                    "startOffset": 18748
                }
            },
            "secId": "s0005",
            "sentence": "This strategy has been successfully tested in animal models using traditional vaccine platforms (recombinant proteins, split vaccine, live attenuated vaccines) [7\u201314] but also worked reasonably well when viral vectors were used [15\u201317].",
            "startOffset": 18520,
            "title": "Introduction"
        },
        {
            "endOffset": 54077,
            "parents": [],
            "secId": "s0095",
            "sentence": "However, the activity of sera from mice vaccinated only with NP+M1 in this assay was low.",
            "startOffset": 53988,
            "title": "Discussion"
        },
        {
            "endOffset": 33700,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Splenocytes were resuspended to 2.5 \u00d7 106 cells/mL and 50 \u00b5L of the cell suspension was added to a 96-well multiscreen filter plate (Merck Millipore).",
            "startOffset": 33550,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 43500,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The DNA-prime/protein boost animals recovered slightly faster than the cHA-vectored group and showed 100% survival (with the difference between the groups not being statistically significant).",
            "startOffset": 43308,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 23284,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The E1 locus and a CMV promotor were used to drive antigen expression for the ChAdOx1 vector.",
            "startOffset": 23191,
            "title": "Viral vectors"
        },
        {
            "endOffset": 29168,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Plates were then washed three times with PBS-T before adding rabbit anti-mouse IgG horseradish peroxidase conjugated antibody (Rockland) in blocking solution for one hour at RT.",
            "startOffset": 28991,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 26377,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "In the VV cHA with cHA group, mice were primed intramuscularly (IM) with 1 \u00d7 108 infectious units (IU) of ChAdOx1-cH14/3 in 50 \u00b5L of PBS, four weeks later they were boosted IM with 1x106 pfu of MVA-cH15/3 in 50 \u00b5L of PBS.",
            "startOffset": 26156,
            "title": "Animal experiments"
        },
        {
            "endOffset": 35749,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Statistical differences between three or more groups were determined by Kruskal-Wallis one-way analysis of variance (ANOVA) with Dunn's correction for multiple comparisons.",
            "startOffset": 35577,
            "title": "Statistics"
        },
        {
            "endOffset": 18277,
            "parents": [],
            "secId": "s0005",
            "sentence": "This is achieved because repeated exposure to the same immunogen (the stalk) leads to strong recall responses while only primary responses are mounted to the drastically different head domains.",
            "startOffset": 18084,
            "title": "Introduction"
        },
        {
            "endOffset": 20776,
            "parents": [],
            "secId": "s0005",
            "sentence": "Challenge viruses included H3N2, H7N9 and H10N8.",
            "startOffset": 20728,
            "title": "Introduction"
        },
        {
            "endOffset": 33142,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Appropriate no serum and no virus controls were used, and the number of hemagglutination positive wells were counted.",
            "startOffset": 33025,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 37536,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Control viral vectors expressing GFP also conferred complete protection against lethal X-31 challenge, suggestive of a non-specific mucosal immune response induced by delivering viral vectors IN.",
            "startOffset": 37341,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 31784,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Following incubation at 37 \u00b0C for 18 h, RDE was inactivated with 2.5% sodium citrate (3 volumes) and by incubating at 56 \u00b0C for 30 min.",
            "startOffset": 31649,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 32520,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "After one hour incubation at 37 \u00b0C, the mixture was removed and cells were washed with PBS.",
            "startOffset": 32429,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 42321,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Mice in the VV cHA-NP+M1 Early and Late groups showed minimal weight loss and were completely protected against H10N8 lethal challenge with the exception of one mouse in the VV cHA-NP+M1 Early group (Fig. 2C).",
            "startOffset": 42112,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 49023,
            "parents": [],
            "secId": "s0095",
            "sentence": "Universal influenza virus vaccines typically target conserved epitopes of the virus.",
            "startOffset": 48939,
            "title": "Discussion"
        },
        {
            "endOffset": 26933,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "VV cHA-NP+M1 Late and VV cHA-NP+M1 Early were primed IM with 1 \u00d7 108 IU of ChAdOx1-cH14/3-NP+M1 in 50 \u00b5L of PBS, four weeks later they were boosted IM with 1 \u00d7 106 pfu of MVA-cH14/3-NP+M1 in 50 \u00b5L of PBS.",
            "startOffset": 26729,
            "title": "Animal experiments"
        },
        {
            "endOffset": 49923,
            "parents": [],
            "secId": "s0095",
            "sentence": "This specifically manifests in terms of the cellular responses, and would likely also benefit the antibody induction against glycoproteins.",
            "startOffset": 49784,
            "title": "Discussion"
        },
        {
            "endOffset": 52812,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0040": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0050": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0055": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0060": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0065": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0070": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0075": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0080": {
                    "endOffset": 52811,
                    "startOffset": 52800
                },
                "b0085": {
                    "endOffset": 52811,
                    "startOffset": 52800
                }
            },
            "secId": "s0095",
            "sentence": "It is unclear if this is an artifact of the mouse model, but three vaccinations were also required in past studies to induce high levels of cross-reactive anti-stalk responses [7,8,10\u201317].",
            "startOffset": 52624,
            "title": "Discussion"
        },
        {
            "endOffset": 36305,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "To determine whether viral vectors expressing cHA constructs could induce anti-stalk antibodies, we vaccinated 6 to 8-week-old female BALB/c mice with a number of viral vectors either IN or IM in a prime-boost-boost vaccination regime (Fig. S1A).",
            "startOffset": 36059,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 45009,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Reactivity was confirmed to be to the stalk and not to the tetramerization domain and hexahistidine tag using a recombinant HA protein that expressed a different trimerization domain and purification tag than the HA used for the protein boost (Fig. S3).",
            "startOffset": 44756,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 19691,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 19690,
                    "startOffset": 19687
                }
            },
            "secId": "s0005",
            "sentence": "While some universal influenza virus vaccine candidates based on the stalk domain of HA aim at inducing antibody responses, other strategies focus on inducing T-cell responses to internal proteins such as nucleoprotein (NP) and the matrix protein 1 (M1) which are highly conserved across seasonal and zoonotic influenza viruses [5].",
            "startOffset": 19359,
            "title": "Introduction"
        },
        {
            "endOffset": 46572,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Robust induction of ADCC was detected in sera from groups VV cHA with cHA Boost, VV cHA-NP+M1 Late and Early when tested against MDCK cells that were infected with A/Philippines/2/82 (H3N2, X-79) (Fig. 4D).",
            "startOffset": 46366,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 17080,
            "parents": [],
            "secId": "s0005",
            "sentence": "The majority of the antibodies induced by these vaccines target the variable, immunodominant HA head domain and are capable of neutralizing the virus by preventing receptor interaction and viral entry.",
            "startOffset": 16879,
            "title": "Introduction"
        },
        {
            "endOffset": 27070,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "These groups differed by the commencement of the prime vaccination \u2013 the Early group was primed four weeks earlier than the third group.",
            "startOffset": 26934,
            "title": "Animal experiments"
        },
        {
            "endOffset": 46827,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "The degree of ADCC induction was markedly lower for the VV NP+M1 group, indicating that the anti-HA stalk antibodies predominantly mediate ADCC activity in these pooled sera and that the contribution of anti-NP and anti-M1 antibodies is relatively small.",
            "startOffset": 46573,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 44042,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Benefits of combining vaccine strategies were more obvious for H3N2 than for H10N8 and were not observed for H7N9.",
            "startOffset": 43928,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 47119,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Given that the strategy to express NP and M1 by viral vectors is primarily aimed at inducing cellular immune responses, we also assessed the induction of influenza virus specific CD8+ T-cells.",
            "startOffset": 46927,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 32331,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Sixty \u00b5l of diluted sera was incubated with 100x of a 50% tissue culture infectious dose (TCID50)/60 \u00b5L of A/Philippines/82 (H3N2, 6:2 A/PR/8/34 reassortant) in a 96-well plate for one hour on a shaker at room temperature.",
            "startOffset": 32109,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 49235,
            "parents": [],
            "secId": "s0095",
            "sentence": "Here we combined a strategy to induce antibodies to the stalk domain using sequential vaccination with cHAs with a vaccine strategy that concurrently induces cellular immunity to conserved epitopes on NP and M1.",
            "startOffset": 49024,
            "title": "Discussion"
        },
        {
            "endOffset": 50934,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0040": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0050": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0055": {
                    "endOffset": 50933,
                    "startOffset": 50923
                },
                "b0060": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0065": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0070": {
                    "endOffset": 50933,
                    "startOffset": 50923
                },
                "b0075": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0080": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0085": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0215": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0220": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0225": {
                    "endOffset": 50868,
                    "startOffset": 50842
                },
                "b0230": {
                    "endOffset": 50933,
                    "startOffset": 50923
                }
            },
            "secId": "s0095",
            "sentence": "Significant work has been performed for group 1 \u2013 based vaccines [7,8,10,12,13,15\u201317,43\u201345] but development of group 2 vaccines is lagging behind [11,14,46].",
            "startOffset": 50777,
            "title": "Discussion"
        },
        {
            "endOffset": 24710,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "To determine an optimal challenge dose of group 2 influenza viruses in vaccinated mice, the mice were divided into 2 groups (3 mice per group per challenge virus dose) (Fig. 1A).",
            "startOffset": 24532,
            "title": "Animal experiments"
        },
        {
            "endOffset": 52510,
            "parents": [],
            "secId": "s0095",
            "sentence": "An explanation for this could be that vaccinating twice with two different cHAs induced high antibody titers against the H3 stalk but cross-reactivity to H7 and H10 was weak.",
            "startOffset": 52336,
            "title": "Discussion"
        },
        {
            "endOffset": 53755,
            "parents": [],
            "refoffsets": {
                "b0245": {
                    "endOffset": 53754,
                    "startOffset": 53747
                },
                "b0250": {
                    "endOffset": 53754,
                    "startOffset": 53747
                },
                "b0255": {
                    "endOffset": 53754,
                    "startOffset": 53747
                }
            },
            "secId": "s0095",
            "sentence": "However, it has recently been shown that human antibodies to these two proteins can activate effector cells and high anti-NP antibody titers have also been demonstrated to be protective in a mouse model [49\u201351].",
            "startOffset": 53544,
            "title": "Discussion"
        },
        {
            "endOffset": 18083,
            "parents": [],
            "secId": "s0005",
            "sentence": "Sequential vaccination with cHAs that have the same stalk but very different head domains can refocus the immune response to the stalk.",
            "startOffset": 17948,
            "title": "Introduction"
        },
        {
            "endOffset": 29366,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Following the secondary antibody incubation, the plates were washed four times with PBS-T to remove residual antibody and the O-phenylenediamine dihydrochloride substrate (Sigma-Aldrich) was added.",
            "startOffset": 29169,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 39790,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "To assess the breadth of protection in mice vaccinated with viral vectors expressing both cHA and NP+M1, we immunized mice using prime-boost/prime-boost-boost regimens (Fig. 2A).",
            "startOffset": 39612,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 23175,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Additionally, A/Perth/16/09 H3 HA was expressed with a GCN4pII trimerization domain and a C-terminal streptavidin-tag for purification to avoid a background signal in enzyme linked immunosorbent assay (ELISA) caused by anti-histidine or anti-trimerization domain antibodies.",
            "startOffset": 22901,
            "title": "Recombinant proteins"
        },
        {
            "endOffset": 43927,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Overall, vaccination with viral vectors expressing cHA-NP+M1 in a prime boost regimen provides complete protection upon challenge with three different group 2 influenza A viruses.",
            "startOffset": 43748,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 37340,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Mice vaccinated intranasally with viral vectors or recombinant protein both were completely protected and lost minimal weight (Fig. S1C).",
            "startOffset": 37203,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 25820,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The exception was the 103 PFU per mouse group for A/Jiangxi-Donghu/346/13 (H10N8) which included only two mice in that group.",
            "startOffset": 25695,
            "title": "Animal experiments"
        },
        {
            "endOffset": 45772,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Assessment of antibody responses against purified A/Philippines/2/82 (H3N2, X-79), A/Shanghai/1/2013 (H7N9, PR8 reassortant) and A/Jiangxi-Donghu/346/2013 (H10N8, PR8 reassortant) viruses showed strong anti-influenza virus antibody responses in all non-control vaccination groups (Fig. 4B).",
            "startOffset": 45482,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 20299,
            "parents": [],
            "secId": "s0005",
            "sentence": "In addition to these viral vectors expressing NP and M1, they have also been supplemented with or given the capacity to express H5 and H7 full length HA.",
            "startOffset": 20146,
            "title": "Introduction"
        },
        {
            "endOffset": 35962,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "In all cases, probability levels<0.05 (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001) were indicative of statistical significance.",
            "startOffset": 35826,
            "title": "Statistics"
        },
        {
            "endOffset": 21212,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Sf9 cells for baculovirus rescue were grown in Trichoplusia ni medium-formulation Hink (TNM-FH) insect cell medium (Gemini Bioproducts) supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (100 U/ml penicillin, 100 \u03bcg/ml streptomycin) solution (Gibco).",
            "startOffset": 20938,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 17947,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 17946,
                    "startOffset": 17943
                }
            },
            "secId": "s0005",
            "sentence": "Chimeric hemagglutinin constructs (cHA) are comprised of a stalk domain derived from seasonal H1, H3 or influenza B virus HAs and HA head domains from avian influenza virus subtypes to which the general population is immunologically na\u00efve to [6].",
            "startOffset": 17701,
            "title": "Introduction"
        },
        {
            "endOffset": 40318,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Groups labeled as VV cHA-NP+M1 Late and VV cHA-NP+M1 Early were vaccinated with viral vectors expressing NP+M1 and cHAs, with a difference in time of vaccination relative to viral challenge.",
            "startOffset": 40128,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 27459,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 27458,
                    "startOffset": 27454
                }
            },
            "secId": "s0030",
            "sentence": "This group received a cH4/3 DNA prime, a cH5/3 protein boost and a final full length H3 protein boost [11].",
            "startOffset": 27352,
            "title": "Animal experiments"
        },
        {
            "endOffset": 45886,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Interestingly, we also found strong reactivity in sera of VV NP+M1 animals, despite a lack of anti-HA antibodies.",
            "startOffset": 45773,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 27253,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The VV Control group was primed IM with 1 \u00d7 108 IU of ChAdOx1-GFP in 50 \u00b5L of PBS, four weeks later animals in this group were boosted IM with 1 \u00d7 106 pfu of MVA-GFP in 50 \u00b5L of PBS.",
            "startOffset": 27071,
            "title": "Animal experiments"
        },
        {
            "endOffset": 47669,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "These results were confirmed by ICS using stimulation with the same peptide.",
            "startOffset": 47593,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 30686,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The infection medium was removed from MDCK cells and they were washed with PBS.",
            "startOffset": 30607,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 34861,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Influenza virus-specific T cell responses were assessed using the ICS assay.",
            "startOffset": 34785,
            "title": "Intracellular cytokine staining (ICS) assay"
        },
        {
            "endOffset": 41975,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "However, these are qualitative observations and substantially larger group numbers would be required in order to determine statistical significance of these differences in weight loss dynamics and recovery rates.",
            "startOffset": 41763,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 34008,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Splenocytes were stimulated at a final concentration of 1 \u00b5g/mL.",
            "startOffset": 33944,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 16599,
            "parents": [],
            "secId": "s0005",
            "sentence": "The effectiveness of annual vaccination in reducing the morbidity and mortality caused by seasonal influenza virus infection strongly depends on the extent to which the selected vaccine strains match the circulating viruses.",
            "startOffset": 16375,
            "title": "Introduction"
        },
        {
            "endOffset": 42750,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Here, vectored cHA vaccination (VV cHA with cHA Boost) led to only 70% survival while all groups receiving NP+M1 or cHA+NP+M1 had 100% survival (Fig. 3B).",
            "startOffset": 42596,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 20498,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 20497,
                    "startOffset": 20490
                },
                "b0175": {
                    "endOffset": 20497,
                    "startOffset": 20490
                }
            },
            "secId": "s0005",
            "sentence": "The induced immune responses are augmented by the naturally adjuvanting nature of these viral vectors [34,35].",
            "startOffset": 20388,
            "title": "Introduction"
        },
        {
            "endOffset": 36348,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "A cH5/3 DNA prime was given to all groups.",
            "startOffset": 36306,
            "title": "Determination of the optimal construct sequence and immunization route for vaccination"
        },
        {
            "endOffset": 28782,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The following day, the plates were washed three times with PBS containing 0.1% Tween-20 (PBS-T) and blocked in blocking solution (3% goat serum (Gibco), 0.5% non-fat milk in PBS-T) for 1 h at room temperature (RT).",
            "startOffset": 28568,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 38247,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "To determine an optimal challenge dose, mice were IM vaccinated with viral vectors (VV), ChAdOx1 and MVA, expressing NP+M1 or GFP as a control (VV NP+M1 and VV Control), in a prime-boost regimen 3 weeks apart.",
            "startOffset": 38038,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 22116,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Viruses were aliquoted and stored at \u221280 \u00b0C.",
            "startOffset": 22072,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 31067,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The cells were incubated in the dark for 10 min before measuring luminescence on a Synergy H1 microplate reader (BioTek).",
            "startOffset": 30946,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 51418,
            "parents": [],
            "secId": "s0095",
            "sentence": "Therefore, we decided to test group 2 cHAs as immunogens and group 2 HA expressing viruses, including H3N2, H7N9 and H10N8, for testing vaccine efficacy in the mouse model.",
            "startOffset": 51246,
            "title": "Discussion"
        },
        {
            "endOffset": 28163,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "A weight loss of more than 25% was considered as a humane endpoint and animals that reached this endpoint were euthanized.",
            "startOffset": 28041,
            "title": "Animal experiments"
        },
        {
            "endOffset": 42542,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "All animals in the other control groups (Mock Control and Na\u00efve) succumbed to infection.",
            "startOffset": 42454,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 42595,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The situation is more complex for the H7N9 challenge.",
            "startOffset": 42542,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 28990,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Serum was then serial diluted 1:3 in blocking solution and incubated at RT for two hours.",
            "startOffset": 28901,
            "title": "Enzyme linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 24241,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0205": {
                    "endOffset": 24192,
                    "startOffset": 24188
                }
            },
            "secId": "s0025",
            "sentence": "The vectors were produced by the Jenner Institute\u2019s Viral Vector Core Facility in T-Rex-293 cells (for ChadOx1, ThermoFisher) or DF-1 cells (MVA) [41] and purified via sucrose cushion centrifugation.",
            "startOffset": 24042,
            "title": "Viral vectors"
        },
        {
            "endOffset": 39101,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "It also demonstrated the protective efficacy of vaccination with NP-M1 constructs alone, as the LD50 values in GFP vaccinated animals were clearly lower than the LD50 values in animals vaccinated with vectors expressing NP and M1.",
            "startOffset": 38871,
            "title": "Determination of the optimal influenza virus challenge setting"
        },
        {
            "endOffset": 34234,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "After washing, the detection antibody was added, and the plates were left for 2 h at room temperature.",
            "startOffset": 34132,
            "title": "Interferon-\u03b3 (IFN\u03b3) enzyme linked immunospot (ELISpot) assay"
        },
        {
            "endOffset": 46183,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "To investigate if this reactivity in the VV NP+M1 vaccination group could be mediated by antibodies to the internal proteins of the virus, we measured antibody responses to recombinant NP and M1 and found reactivity in groups that received vectors expressing the NP+M1 fusion construct (Fig. 4C).",
            "startOffset": 45887,
            "title": "Characterization of the antibody response induced upon vaccination"
        },
        {
            "endOffset": 30424,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The cells and virus were then incubated for 24 h at 37 \u00b0C.",
            "startOffset": 30366,
            "title": "Antibody-dependent cellular cytotoxicity (ADCC) reporter assay"
        },
        {
            "endOffset": 32428,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Hundred \u00b5l of virus-serum mixture was transferred onto MDCK cells that had been washed with PBS.",
            "startOffset": 32332,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 40035,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Mice in the VV cHA with cHA Boost group were vaccinated with monovalent viral vectors expressing only the chimeric HAs (as tested in Fig. S1) followed by a recombinant cHA protein boost to induce a strong antibody response against the HA stalk.",
            "startOffset": 39791,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 49590,
            "parents": [],
            "refoffsets": {
                "b0210": {
                    "endOffset": 49589,
                    "startOffset": 49585
                }
            },
            "secId": "s0095",
            "sentence": "Combining these two strategies was successful and we did not measure any cellular immune interference toward NP+M1 due to expression of a second antigen which has previously been observed in viral vectored vaccines [42].",
            "startOffset": 49370,
            "title": "Discussion"
        },
        {
            "endOffset": 35380,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Data was acquired on a BD-LSRII and analyzed using FlowJo software.",
            "startOffset": 35313,
            "title": "Intracellular cytokine staining (ICS) assay"
        },
        {
            "endOffset": 22448,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Virus was then pelleted by centrifugation at 25,000 rpm using a SW-28 rotor in a Beckman L7-65 ultracentrifugre for 2 h at 4 \u00b0C in 1 \u00d7 NTE buffer (0.5 mM NaCl, 10 mM Tris-HCl, pH 7.5, 5 mM EDTA) over a 30% sucrose cushion.",
            "startOffset": 22226,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 51245,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 51244,
                    "startOffset": 51237
                },
                "b0240": {
                    "endOffset": 51244,
                    "startOffset": 51237
                }
            },
            "secId": "s0095",
            "sentence": "Furthermore, levels of antibodies that target the group 2 HA stalk are much lower in the human population than antibodies that target the group 1 HA stalk [47,48].",
            "startOffset": 51082,
            "title": "Discussion"
        },
        {
            "endOffset": 42453,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Three mice survived in the viral vector GFP (VV Control) group, albeit with severe weight loss (24%) and late, incomplete recovery.",
            "startOffset": 42322,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 40127,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "VV NP+M1 group mice were vaccinated with viral vectors expressing the NP+M1 fusion protein.",
            "startOffset": 40036,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 48472,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "No reactivity in any of the assays was detected for the VV cHA with cHA Boost or the control groups.",
            "startOffset": 48372,
            "title": "Vaccination with viral vectors expressing NP+M1 induces strong IFN\u03b3 CD8+ T cell responses in mice"
        },
        {
            "endOffset": 50538,
            "parents": [],
            "secId": "s0095",
            "sentence": "This is an important finding since a universal influenza virus vaccine that does not induce durable protection is of limited use although it is unclear if this finding in the mouse model translates to humans.",
            "startOffset": 50330,
            "title": "Discussion"
        },
        {
            "endOffset": 26728,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The VV NP+M1 experimental group was primed IM with 1x108 IU of ChAdOx1 NP+M1 in 50 \u00b5L of PBS, four weeks later the animals were boosted IM with 1x106 pfu of MVA-NP+M1 in 50 \u00b5L of PBS.",
            "startOffset": 26545,
            "title": "Animal experiments"
        },
        {
            "endOffset": 23606,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For bivalent vaccines a 2A ribosome skipping site was inserted between NP+M1 and cH14/3.",
            "startOffset": 23518,
            "title": "Viral vectors"
        },
        {
            "endOffset": 53232,
            "parents": [],
            "secId": "s0095",
            "sentence": "An alternative possibility is, that the cross-reactivity was driven by the combination of viral vectored followed by recombinant protein vaccine.",
            "startOffset": 53087,
            "title": "Discussion"
        },
        {
            "endOffset": 35312,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Five hours later splenocytes were permeabilized and stained for the presence of CD8\u03b1 (53-6.7, BioLegend), IFN\u03b3 (XMG1.2, BioLegend), tumor necrosis factor \u03b1 (TNF\u03b1, MP6-XT22, BioLegend) and interleukin 2 (IL2, Jes6-5H4, BioLegend).",
            "startOffset": 35083,
            "title": "Intracellular cytokine staining (ICS) assay"
        },
        {
            "endOffset": 54669,
            "parents": [],
            "refoffsets": {
                "b0265": {
                    "endOffset": 54668,
                    "startOffset": 54661
                },
                "b0270": {
                    "endOffset": 54668,
                    "startOffset": 54661
                },
                "b0275": {
                    "endOffset": 54668,
                    "startOffset": 54661
                },
                "b0280": {
                    "endOffset": 54668,
                    "startOffset": 54661
                }
            },
            "secId": "s0095",
            "sentence": "It has been demonstrated that pre-existing CD4+ T-cell immunity toward HA, generated by seasonal influenza viruses, can augment the humoral response toward both homologous and heterologous HA and will be important to consider when studying our vaccine in a influenza virus-exposed population [53\u201356].",
            "startOffset": 54369,
            "title": "Discussion"
        },
        {
            "endOffset": 41199,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "This was expected from the challenge dose finding experiments and allowed for a window in which an improvement of combining the two approaches can be observed.",
            "startOffset": 41040,
            "title": "cHA-NP+M1 vaccination protects mice against influenza virus challenge"
        },
        {
            "endOffset": 31523,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Pre-challenge sera from vaccinated mice were pooled according to their groups.",
            "startOffset": 31445,
            "title": "Microneutralisation assay"
        },
        {
            "endOffset": 52623,
            "parents": [],
            "secId": "s0095",
            "sentence": "A third boost was needed to induce stronger cross-reactivity, potentially due to additional affinity maturation.",
            "startOffset": 52511,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19310163",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Guha",
                "initial": "G.",
                "last": "Asthagiri Arunkumar"
            },
            {
                "email": null,
                "first": "Meagan",
                "initial": "M.",
                "last": "McMahon"
            },
            {
                "email": null,
                "first": "Vincent",
                "initial": "V.",
                "last": "Pavot"
            },
            {
                "email": null,
                "first": "Mario",
                "initial": "M.",
                "last": "Aramouni"
            },
            {
                "email": null,
                "first": "Andriani",
                "initial": "A.",
                "last": "Ioannou"
            },
            {
                "email": null,
                "first": "Teresa",
                "initial": "T.",
                "last": "Lambe"
            },
            {
                "email": "sarah.gilbert@ndm.ox.ac.uk",
                "first": "Sarah",
                "initial": "S.",
                "last": "Gilbert"
            },
            {
                "email": "florian.krammer@mssm.edu",
                "first": "Florian",
                "initial": "F.",
                "last": "Krammer"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.07.095",
        "firstpage": "5567",
        "issn": "0264410X",
        "keywords": [
            "Influenza",
            "M1",
            "NP",
            "Stalk",
            "T-cell immunity",
            "Universal influenza virus vaccine"
        ],
        "lastpage": "5577",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice"
    }
}